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ABSTRACT
The cation-Cl- cotransporter (CCC) family comprises seven well-characterized molecules: 
a thiazide-sensitive Na+-Cl- cotransporter (NCC), two loop diuretic-sensitive Na+-K+-2Cl- 
cotransporters (NKCC1-2), and four K+-Cl- cotransporters (KCC1-4). These membrane 
proteins are involved in several physiological activities including transepithelial ion 
absorption and secretion, and cell volume regulation. In neuronal tissues, NKCC1 and 
KCC2 are especially important in determining the intracellular Cl- levels and hence the 
neuronal responses to inhibitory neurotransmitters GABA and glycine. Loss-of-function 
mutations to three members of the CCC family have been identifi ed as the cause for two 
inherited kidney diseases, Bartter’s and Gitelman’s diseases, and for one neurological 
disease, Anderman’s disease.
One aim of the work was to elucidate the possible roles for CCC isoforms in the 
control of nervous system development. For this purpose we conducted a comprehensive 
analysis of the distribution patterns of KCC1-4 and NKCC1 in rodent central nervous 
system (CNS) during embryonic development. Characterization of the CCC isoform 
distribution in the embryonic rodent brain revealed that KCC2 mRNA is developmentally 
up-regulated and follows neuronal maturation, and that NKCC1 and KCC4 transcripts 
are highly expressed in the proliferative zones of subcortical regions around the peak of 
neurogenesis. KCC1 and KCC3 mRNA were shown to display generally low expression 
throughout the embryogenesis. These expression profi les suggest a role for CCC isoforms 
in maturation of synaptic responses and in the regulation of neuronal proliferation during 
embryogenesis.
The major aim of this work was to study the biological consequences of the defi ciency 
of a neuronal-specifi c KCC2 isoform in the adult CNS by generating transgenic mice that 
retain 15-20% of normal KCC2 levels. In addition, by using these mice as a tool for in 
vivo pharmacological analysis, we have investigated the requirements for KCC2 in tonic 
versus phasic GABA
A
 receptor-mediated inhibition. In contrast to the KCC2 null mice 
that die at birth, KCC2-defi cient mice display normal reproduction and life span but have 
reduced body weight (-20%). The mice show several behavioral abnormalities, including 
increased anxiety-like behavior, impaired performance in a water maze, alterations in 
nociceptive processing, and increased susceptibility for chemically-induced seizures. 
In contrast, the mice displayed apparently normal spontaneous locomotor activity and 
motor coordination.
Pharmacological analysis of KCC2-defi cient mice revealed reduced sensititivity to 
diazepam, but normal gaboxadol-induced sedation, neurosteroid hypnosis and alcohol-
induced motor impairment. Electrophysiological recordings from CA1-CA3 subregions 
of the hippocampus showed that KCC2 defi ciency affected the reversal potentials of both 
the phasic and tonic GABA currents, and that the tonic conductance was not affected. 
The results suggest that requirement for KCC2 in GABAergic neurotransmission may 
differ among several functional systems in the CNS, which is possibly due to the more 
critical role of KCC2 activity in phasic compared to tonic GABAergic inhibition.
1Review of the Literature
1.1 Introduction to cation-Cl- 
cotransporters
In all cells and organelles, the uptake 
and effl ux of crucial compounds such as 
sugars, amino acids, nucleotides, inorganic 
ions, and drugs is controlled by membrane 
transporter proteins. Approximately 5% 
(>2000) of all human genes are transporter-
related (Hediger et al., 2004), consistent 
with the critical role of transporters in 
cell homeostasis. One class of membrane 
transporters consists of families of the 
solute carrier (SLC) gene series, which 
encode uniporters (passive transporters), 
cotransporters (coupled transporters), and 
antiporters (exchangers). In the human 
genome, 43 SLC families including a 
total of 319 transporter genes have been 
identifi ed (Hediger et al., 2004). One of 
the identified SLC families is a cation-
Cl- cotransporter (solute carrier family 12, 
SLC12) gene family, which contains all 
Table 1. SLC12A(1-9), the electroneutral cation-Cl- coupled cotransporter family
NA, information not available
genes that encode electroneutral cation-Cl- 
coupled cotransporters (CCCs) (Gamba, 
2005). Nine members of the CCC family 
have been identifi ed in humans (Table 1).
The phylogenetic tree of CCCs (Fig. 1) 
reveals two major subdivisions. One branch 
comprises cotransporters that exhibit 
~70% identity and transport K+ coupled 
with Cl-. The other branch includes carriers 
that display ~50% identity and transport 
Na+ (with or without K+) coupled with Cl-. 
The members of the gene family share a 
common basic topology, as assessed by 
hydropathy profi les of predicted proteins. 
The CCCs contain hydrophilic C- and 
N-terminal regions flanking a central 
hydrophobic domain containing 12 
putative transmembrane (TM) domains. 
The central domain is the protein section 
that possesses the highest conservation, 
whereas the N-terminal domain is the 
most variable segment of these proteins 
(Mercado et al., 2004).
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gene name 
Protein
name
Human gene 
locus
Number of 
residues, aa 
Molecular
Mass, kDa 
Reference 
SLC12A1 NKCC2 15q15-q21.1 1099 121 (Simon et al., 1996a) 
SLC12A2 NKCC1 5q23.3 1212 132 (Payne et al., 1995) 
SLC12A3 NCC 16q13 1030 114 (Simon et al., 1996b) 
SLC12A4 KCC1 16q22.1 1011-1085 118-120 (Gillen et al., 1996) 
(Gamba, 2005) 
SLC12A5 KCC2 20q12-q13.1 1116 123.5 (Sallinen et al., 2001) 
(Song et al., 2002) 
SLC12A6 KCC3a 
KCC3b 
15q14 1150 
1099
128
122
(Howard et al., 2002) 
SLC12A7 KCC4 5p15.3 1083 119 (Mount et al., 1999) 
SLC12A8 SLC12A8 3q21 714 NA (Hewett et al., 2002) 
SLC12A9 CIP1 7q22 914 96 (Caron et al., 2000) 
2There is one structural feature that 
sets the two major CCC subdivisions apart. 
The K+-Cl- cotransporters and CIP1 (for 
cotransporter-interacting-protein 1) have 
a large extracellular loop between TM5 
and TM6 that contains several consensus 
N-linked glycosylation sites, whereas the 
Na+ coupled cotransporters and SLC12A8 
have a similar loop between TM7 and 
TM8. Besides their structures and ligands, 
the CCCs are classifi ed according to their 
inhibitors. The Na+-Cl- cotransporter 
(NCC) is specifically inhibited by the 
benzothiadiazine (thiazide) class of diuretic 
agents (Stokes, 1984), and the Na+-K+-
2Cl- cotransporter (NKCC) is specifi cally 
sensitive to ‘loop’-type diuretics of the 
sulfamoyl-benzoic acid class such as 
bumetanide and furosemide (O’Grady 
et al., 1987). The K+-Cl- cotransporter 
(KCC) is sensitive to both furosemide and 
bumetanide. Furosemide has about equal 
potency for both NKCC and KCC, wheras 
bumetanide is signifi cantly more effi cient 
(~500-fold) inhibitor of NKCC than KCC 
(Payne et al., 2003).
Fig. 1. Phylogenetic tree of human cation-chloride cotransporters (solute carrier family 
12, SLC12). The percentage of identical residues between aligned protein sequences is 
shown at branch points (modifi ed from Gamba, 2005).
The principal function of these 
proteins is to translocate Cl- accompanied 
with cations across the plasma membrane. 
This occurs by Na+-Cl-, Na+-K+-2Cl-, 
or K+-Cl- stoichiometry and is thus an 
electroneutral process (produces no net 
charge movement across the membrane). 
The CCCs are secondarily active 
transporters that derive energy for the 
transport from the electrochemical ion 
gradients across the plasma membrane, 
generated and maintained by primary-
active transporters (Na+-K+-ATPase). The 
plasma membrane cation gradients also 
determine the direction of CCC transport. 
NCC and NKCC utilize the driving force 
of the Na+ gradient and thus translocate 
ions inside the cell, whereas KCC exploits 
the driving force of the K+ gradient and 
extrudes ions from the cell. Because Na+-
K+-ATPase quickly re-establishes the 
physiological Na+ and K+ concentrations 
across the plasma membrane, the net effect 
of CCC activity is Cl- movement into or 
out of the cell.
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fundamental physiological processes, 
including regulation of cell volume in 
both epithelial and nonepithelial cells, 
intracellular Cl- activity and thus the 
neuronal response to γ-aminobutyric acid 
(GABA) and glycine, and transepithelial 
ion absorption and secretion (Gamba, 
2005).
1.2 Isoforms of the cation-Cl- 
cotransporter gene family
1.2.1 Na+-K+-Cl- and Na+-Cl- 
cotransporters
Evidence for a loop diuretic-sensitive Na+-
K+-Cl- cotransport (NKCC) mechanism 
was fi rst presented in 1980 (Geck et al., 
1980). Two isoforms have been identifi ed 
and form the NKCC subfamily of cation-
Cl- cotransporters in vertebrates. These 
NKCC carriers are present in many 
different tissues from a wide variety of 
animal species. Transport by NKCC 
serves to maintain high intracellular 
Cl- ([Cl-]
i
), which is used by epithelial 
tissues to promote net salt transport 
and by neural cells to regulate chloride 
homeostasis. The transport is inhibited 
by the 5-sulfamoylbenzoic acid loop 
diuretics furosemide, bumetanide and 
bentzmetanide. In most cell types, NKCC 
transport is activated by cell shrinkage 
as a part of cellular regulatory volume 
increase mechanisms (Haas and Forbush, 
III, 2000;Russell, 2000).
NKCC1 is expressed in a wide variety 
of secretory epithelial and non-epithelial 
cells, and is often referred to as the 
housekeeping or secretory isoform (Haas 
and Forbush, III, 2000;Russell, 2000). 
In epithelial cells, the cotransporter is 
expressed on the basolateral membrane 
and plays a critical role in providing cells 
with Cl- that is secreted through the apical 
membrane (Evans et al., 2000;Shillingford 
et al., 2002;Bachmann et al., 2003). In 
the nervous system, NKCC1 plays a 
critical role in the regulation and control 
of neuronal excitability (Sung et al., 
2000;Yamada et al., 2004;Dzhala et al., 
2005). In most cell types studied, this 
carrier appears to be especially important 
in the maintenance of cellular volume 
(Russell, 2000).
NKCC1 was f irst identif ied at 
the molecular level from a shark (Xu 
et al., 1994), and subsequently from 
several vertebrate species (Delpire et 
al., 1994;Payne et al., 1995;Yerby et al., 
1997;Moore-Hoon and Turner, 1998;Cutler 
et al., 2000).
No human disease has been linked 
with inactivating mutations in SLC12A2, 
but physiological roles for the carrier 
have been revealed from analysis of 
NKCC1 knock-out (KO) mice. NKCC1 
is expressed in all tissues, but displays 
especially high expression in the inner ear 
and the salivary gland where it contributes 
to the formation of endolymph (Delpire 
et al., 1999) and the production of saliva 
(Flagella et al., 1999), respectively. 
Consistent with this, NKCC1 KO mice 
are deaf and exhibit classic shaker/waltzer 
behavior, which is indicative of inner 
ear defects that result from decreased 
endolymph secretion (Delpire et al., 
1999;Flagella et al., 1999). In addition, 
these mice display severe impairment 
in the production of saliva (Evans et al., 
2000). Consistent with the ubiquitous 
expression profi le of the protein, NKCC1 
KO mice show additional phenotypes in 
a variety of organs, including alterations 
in locomotion and nociceptive processing 
(Sung et al., 2000;Pace et al., 2000), 
defects in gastrointestinal ion transport 
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to defective spermatogenesis (Pace et 
al., 2000), and reduced blood pressure 
(Flagella et al., 1999).
NKCC2 and NCC are present exclusively 
in the kidney (Gamba et al., 1994;Payne 
and Forbush, III, 1994). In humans, 
inactivating mutations in SLC12A1 
have been shown to underlie the 
pathophysiology of Bartter’s disease 
(Simon et al., 1996a), and mutations to the 
SLC12A3 have been shown to be the cause 
for Gitelman’s syndrome. Bartter’s disease 
is characterized by severe polyuria and 
electrolyte imbalance (Simon et al., 1996a), 
whereas Gitelman’s disease is defined 
by hypokalemia, hypomagnesaemia, 
and metabolic alkalosis (Gitelman et al., 
1969;Simon et al., 1996b).
1.2.2 K+-Cl- cotransporter
KCC mediates the coupled transport of 
K+ and Cl- across plasma membranes, 
and was fi rst identifi ed as a swelling-and 
N-ethylmaleimide-activated K+ efflux 
pathway in red blood cells (Dunham et al., 
1980;Lauf and Theg, 1980;Dunham and 
Ellory, 1981). K+-Cl- cotransport plays a 
signifi cant role in the ionic and osmotic 
homeostasis of many cell types and has 
been implicated in several physiological 
and pathophysiological processes, 
including the cell regulatory volume 
decrease (Lauf et al., 1992), transepithelial 
salt absorption (Amlal et al., 1994), 
renal K+ secretion (Ellison et al., 1985), 
myocardial K+ loss during ischemia (Yan 
et al., 1996), cell growth regulation (Shen 
et al., 2001), human cervical and ovarian 
carcinogenesis (Shen et al., 2004), and the 
control of neuronal Cl- activity (Rivera 
et al., 1999). At present, four different 
isoforms (KCC1-4) have been identifi ed 
and form the KCC subfamily of CCCs. 
Within the subfamily, KCC2 and KCC4 
form a closely related subgroup, whereas 
KCC1 is more homologous to KCC3 
(Mount et al., 1999).
KCC1 is widely expressed in mammalian 
tissues and is considered to represent 
a housekeeping KCC isoform that 
maintains volume homeostasis in most 
cells (Gillen et al., 1996). Heterologous 
expression of KCC1 in Xenopus laevis 
oocytes reveals minimal KCC activity 
under isotonic conditions, but a strong cell 
swelling-induced activation of transport 
under hypotonic conditions (Su et al., 
1999;Mercado et al., 2000). However, 
when KCC1 is expressed in human 
embryonic kidney (HEK-293) cells, the 
carrier displays signifi cant isotonic activity 
which is further activated by cell swelling 
(Gillen et al., 1996;Holtzman et al., 1998). 
Compared to other KCCs that display very 
similar transport kinetics, KCC1 exhibits 
very low affinity for the transported K+ 
and Cl- ligands (Gamba, 2005).
KCC1 cDNAs have been obtained 
from several species (Gillen et al., 
1996;Holtzman et al., 1998;Pellegrino et 
al., 1998;Su et al., 1999). Human KCC1 
is expressed as multiple hKCC1 isoforms; 
there are at least six open reading frames 
encoding for almost identical hKCC1 
isoforms, and several splice variants 
for hKCC1 have also been described 
(Pellegrino et al., 1998;Adragna et al., 
2004;Crable et al., 2005).
The physiological role of KCC1 is 
still unclear. There are no human diseases 
directly linked to mutations in SLC12A4, 
and mice with genetic alterations to 
KCC1 have not yet been described. The 
majority of KCC activity in red blood 
cells has been attributed to KCC1, with 
some contribution of KCC3 and KCC4 
Review of the Literature
5(Lauf et al., 2001;Crable et al., 2005). 
KCC activity in the process of regulatory 
volume decrease is physiologically 
relevant to red blood cell maturation 
when the erythrocyte attains the fi nal cell 
volume (Lauf et al., 1992). While mature 
circulating red blood cells express KCC 
activity at low or unmeasurable levels, the 
activity is elevated in reticulocytes and 
young red blood cells, as well as in red 
blood cells containing abnormal sickle 
hemoglobin (Lauf et al., 1992). In this 
regard, increased KCC activity is thought 
to play a major role in certain human 
hemoglobinopathies, such as sickle cell 
disease (Joiner, 1993). A recent report 
demonstrated aberrant expression of one 
of the KCC1 splice variants in sickle cells 
compared to normal reticulocytes (Crable 
et al., 2005), indicating a possible role for 
KCC1 in the pathogenesis of sickle cell 
disease.
KCC2 displays a neuron-specifi c expression 
pattern and is abundantly expressed 
in most neurons throughout the CNS, 
but absent from the peripheral nervous 
system (PNS) (Payne et al., 1996;Rivera 
et al., 1999). The cotransporter plays a 
crucial role in determining intracellular 
Cl- activity and thus the neuronal response 
to inhibitory neurotransmitters GABA 
and glycine (Rivera et al., 1999). KCC2 
is unique among the KCCs by mediating 
constitutive KCC activity under isotonic 
conditions, as assessed in both X. laevis 
oocytes and mammalian cells (Payne, 
1997;Strange et al., 2000;Song et al., 
2002;Gagnon et al., 2006). This unique 
feature of KCC2 activity is due to a 15 
residue domain in the C-terminus, which 
is not present in other KCC isoforms 
(Mercado et al., 2006). Similar to other 
KCC isoforms, KCC2 is also activated in 
response to cell swelling (Strange et al., 
2000;Song et al., 2002;Mercado et al., 
2006).
KCC2 functions postsynaptically 
to extrude Cl- from the cell and thus 
establishes the fast hyperpolarizing 
inhibitory responses mediated by GABA 
and glycine (Rivera et al., 1999;Hubner 
et al., 2001b). The importance of KCC2 
in the control of neuronal excitability is 
underscored in KCC2-deficient mouse 
models. KCC2 KO mice show signifi cantly 
increased depolarizing GABA responses 
and die immediately after birth due to 
defi cits in the respiratory system (Hubner 
et al., 2001b), and KCC2 knock-down 
animals retaining 5-8% of normal KCC2 
levels exhibit frequent generalized seizures 
and die shortly after birth (Woo et al., 
2002). In addition, impaired expression 
and/or activity of KCC2 has been 
implicated in several forms of neuronal 
injury (Nabekura et al., 2002;Toyoda 
et al., 2003;Jin et al., 2005), and in the 
genesis of neuropathic pain and temporal 
lobe epilepsy (Cohen et al., 2002;Coull et 
al., 2003).
KCC3 is expressed in multiple tissues, 
including kidney, heart, brain, muscle, 
and lung, and has been identifi ed at the 
molecular level from human and mouse 
tissues (Mount et al., 1999;Hiki et al., 
1999;Race et al., 1999;Pearson et al., 
2001;Mercado et al., 2005). KCC3 is 
activated by cell swelling, and displays 
isotonic activity when functionally 
expressed in HEK-293 cells, but not in the 
Xenopus oocyte expression system (Hiki 
et al., 1999;Race et al., 1999;Mercado et 
al., 2005).
The human KCC3 gene contains 26 
coding exons and harbors two alternative 
f irst coding exons (exons 1a and 1b) 
resulting in two major KCC3 isoforms, 
KCC3a and KCC3b, respectively (Howard 
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predicts a 1150 residue protein with a 
molecular weight of 128 kDa, whereas 
KCC3b is 1099 residue protein with a 
molecular weight of 122 kDa (Mount et 
al., 1999;Mercado et al., 2005). KCC3a 
expression is more widespread than that 
of KCC3b, which is particularly abundant 
in kidney (Pearson et al., 2001;Mercado 
et al., 2005). Furthermore, a recent report 
stated the existence of three additional N-
terminal isoforms of mouse and human 
KCC3 proteins (Mercado et al., 2005).
Loss-of-function mutations in 
SLC12A6 are the cause of peripheral 
neuropathy associated with agenesis of 
the corpus callosum (Howard et al., 2002). 
This disorder, also known as Anderman’s 
disease, is an autosomal recessive disease 
characterized by progressive sensorimotor 
neuropa thy,  men ta l  r e t a rda t ion , 
dysmorphic features, and complete or 
partial agenesis of the corpus callosum 
(Dupre et al., 2003). In addition, rare 
variants of SLC12A6 have been associated 
with bipolar disorder (Meyer et al., 2005). 
Homozygous inactivation of Slc12a6 in 
mice replicates the peripheral neuropathy 
phenotype of Anderman’s disease, but 
not the morphological changes in corpus 
callosum associated with the disease 
(Howard et al., 2002;Boettger et al., 2003). 
In addition to peripheral neuropathy, KCC3 
KO mice display arterial hypertension and 
slowly progressive deafness (Boettger et 
al., 2003). Furthermore, experiments in 
cultured cells suggest a role for KCC3 in 
cell growth regulation (Shen et al., 2001).
KCC4 shows a wide tissue distribution 
pattern and is highly expressed in kidney, 
heart, lung, spinal cord, and the PNS 
(Mount et al., 1999;Velazquez and Silva, 
2003;Karadsheh et al., 2004). Functional 
expression of KCC4 in Xenopus oocytes 
reveals robust activation of KCC transport 
by cell swelling, with minimal activity 
under isotonic conditions (Mount et al., 
1999;Mercado et al., 2000;Gamba, 2005).
Physiological roles for KCC4 have 
been elucidated in KCC4 KO mice. These 
mice were normal at birth, but the cochlear 
hair cells rapidly degenerated after 
beginning of hearing at postnatal day 14 
(P14), which led to a quick deterioration 
of hearing ability and to almost complete 
deafness after the second week of life 
(Boettger et al., 2002). In addition, KCC4 
KO mice develop renal tubular acidosis 
(Boettger et al., 2002), indicating a role 
for KCC4 in acid-base metabolism.
1.2.3 Cotransporter-interacting-protein 
and solute carrier family 12 member 8
SLC12A8 and CIP1 are the two most 
distant members of the CCC family 
(Caron et al., 2000;Hewett et al., 2002). 
Transcripts for these proteins are expressed 
widely in several tissues, including brain 
and kidney (Caron et al., 2000;Hewett et 
al., 2002). The precise functions of CIP1 
and SLC12A8 have remained elusive. 
Functional expression flux studies have 
not been able to identify the transport 
substrates for these proteins, and thus these 
family members remain orphan members 
of the CCC gene family. CIP1 is, however, 
able to inhibit the functional expression 
of NKCC1 by directly interacting with 
endogenous NKCC1 in vitro (Caron 
et al., 2000), and suggestive evidence 
for the role of SLC12A8 in psoriaris 
pathogenesis is accumulating (Hewett et 
al., 2002;Huffmeier et al., 2005).
1.2.4 Expression of cation-Cl- 
cotransporter isoforms within the nervous 
system
Except for NCC and NKCC2, all other 
members of the CCC family have been 
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These proteins are expressed broadly and 
show wide expression patterns with cell-
specific variations throughout the adult 
nervous system (Payne et al., 1996;Plotkin 
et al., 1997b;Kanaka et al., 2001;Pearson 
et al., 2001;Yan et al., 2001;Wang et al., 
2002;Mikawa et al., 2002;Ueno et al., 
2002;Okabe et al., 2002;Okabe et al., 
2003;Balakrishnan et al., 2003;Karadsheh 
et al., 2004;Bartho et al., 2004;Le Rouzic 
et al., 2006).
NKCC1. In the adult rodent brain, NKCC1 
mRNA expression is widely distributed but 
generally low, with the strongest expression 
restricted mainly to the granule cells of the 
cerebellum and choroid plexus (Plotkin 
et al., 1997a;Kanaka et al., 2001;Mikawa 
et al., 2002). NKCC1 transcripts are 
expressed in both neuronal and non-
neuronal cells (Kanaka et al., 2001). The 
neuronal NKCC1 mRNA expression is 
generally low, but exists in several regions 
of the nervous system including the 
olfactory bulb, hippocampus, trigeminal 
nuclei, amygdala, thalamus, piriform 
cortex, spinal cord, and somatosensory 
neurons (Sung et al., 2000;Kanaka et 
al., 2001;Wang et al., 2002;Okabe et 
al., 2002;Toyoda et al., 2005;Wang et 
al., 2005). NKCC1 expression is high 
in white matter tracts, such as corpus 
callosum, internal capsule and cerebral 
peduncle (Kanaka et al., 2001;Hubner et 
al., 2001a), and has also been detected in 
astrocytes within cortex, corpus callosum, 
hippocampus, and cerebellum (Yan et al., 
2001). In addition, NKCC1 expression 
has been detected in cultured spinal cord 
oligodendrocytes (Hoppe and Kettenmann, 
1989;Wang et al., 2003), and in cerebral 
microvascular endothelial cells (O’Donnell 
et al., 1995).
In the postnatal rat brain, NKCC1 
expression peaks in the f irst week of 
postnatal life and then declines from 
P14 to adult (Plotkin et al., 1997b;Wang 
et al., 2002). On P7, NKCC1 mRNA 
expression is strongest in the cortex, 
hippocampus, and cerebellum (Plotkin et 
al., 1997b;Mikawa et al., 2002).
KCC1. The expression profile of KCC1 
mRNA resembles the NKCC1 mRNA 
expression pattern in the adult nervous 
system (Kanaka et al., 2001). The 
expression of KCC1 transcripts is wide but 
generally weak, and restricts mainly to the 
cerebellar granule cells and choroid plexus 
(Kanaka et al., 2001;Mikawa et al., 2002). 
KCC1 mRNA is expressed in neuronal 
and non-neuronal cells, and displays a 
moderate to low expression within several 
regions of the nervous system such as the 
olfactory bulb, hippocampus, superior 
colliculus, cerebral cortex, piriform 
cortex, thalamus, amygdala, spinal cord, 
dorsal root ganglia, posterior hypothalamic 
nucleus, and trigeminal nuclei (Kanaka et 
al., 2001;Okabe et al., 2002;Okabe et al., 
2003;Toyoda et al., 2005). In addition, 
KCC1 mRNA is expressed in white matter, 
including internal capsule and corpus 
callosum, thus suggesting glial expression 
(Kanaka et al., 2001;Wang et al., 2002).
KCC2. KCC2 displays a neuron-specifi c 
expression pattern (Payne et al., 1996). In 
the adult CNS, KCC2 mRNA is expressed 
by most neurons and shows a particularly 
strong expression in pyramidal neurons 
of CA1-CA3 regions of the hippocampus 
and the cortical layer V, granule cells 
and Purkinje neurons of the cerebellum, 
granule neurons of the olfactory bulb, 
spinal cord motoneurons, and piriform 
cortex (Lu et al., 1999;Kanaka et al., 
2001;Le Rouzic et al., 2006). KCC2 
transcripts are also expressed strongly 
in all nuclei of the amygdala, with the 
strongest expression in the medial nuclei 
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In the basal ganglia, KCC2 mRNA is 
highly expressed in the caudate putamen 
and nucleus accumbens, and moderately 
in the globus pallidus (Kanaka et 
al., 2001). In the thalamus, KCC2 is 
abundant in all thalamic nuclei except 
the reticular nucleus (Bartho et al., 
2004). The thalamic KCC2 expression is 
most prominent in the primary sensory 
relay nuclei (f irst order nuclei), being 
strongest in the ventral posterolateral 
and ventral posteromedial nuclei (Bartho 
et al., 2004). In addition, KCC2 mRNA 
is highly expressed in the lateral dorsal 
thalamic nucleus, zona incerta, rhomboid 
thalamic nucleus, subthalamic nucleus, 
parafascicular thalamic nucleus, and 
ventral genigulate body (Kanaka et 
al., 2001). In the hypothalamic nuclei, 
the expression levels of KCC2 mRNA 
vary a lot (Kanaka et al., 2001). A very 
strong KCC2 mRNA expression is 
observed in the lateral hypothalamic 
area, ventromedial hypothalamic nucleus, 
dorsal premammillary nucleus, medial 
preoptic area, and supraoptic nucleus 
(Kanaka et al., 2001;Le Rouzic et al., 
2006). KCC2 mRNA is not, however, 
expressed in the dorsolateral part of the 
paraventricular nucleus, suprachiasmatic 
nucleus, and ventromedial part of the 
supraoptic nucleus (Kanaka et al., 2001). 
In the midbrain, KCC2 mRNA expression 
is strong in the interpeduncular nucleus, 
central gray, red nucleus, and moderate 
in the substantia nigra pars compacta and 
pars reticulata (Kanaka et al., 2001). KCC2 
is not expressed in the dopaminergic 
neurons of substantia nigra (Gulacsi 
et al., 2003). In the pons and medulla, 
KCC2 mRNA expression is strong in the 
pretectal area, superior colliculus, superior 
olivary complex, ventral lateral lemniscus, 
inferior colliculus, and moderate in most 
nuclei including the dorsal tegmental 
nucleus, motor trigeminal nucleus, 
principal trigeminal nucleus, cerebellar 
nuclei, ventral cochlear nucleus, medial 
vestibular nucleus, solitary nucleus, 
spinal trigeminal nucleus, hypoglossal 
nucleus, facial nuclei, and inferior olive 
nucleus (Kanaka et al., 2001;Ueno et al., 
2002;Balakrishnan et al., 2003). KCC2 
mRNA expression is, however, absent 
in the mesencephalic trigeminal nucleus 
(Kanaka et al., 2001;Toyoda et al., 2005). 
Finally, KCC2 transcripts are moderately 
expressed in the dorsal and vetral horns 
of the spinal cord (Kanaka et al., 2001), 
and not detected in the peripheral nervous 
system (Rivera et al., 1999;Hubner et al., 
2001b;Toyoda et al., 2005).
Electron microscopy analyses in 
rat hippocampus and thalamus have 
revealed strong KCC2 expression in the 
vicinity of excitatory inputs (Gulyas 
et al., 2001;Bartho et al., 2004). In rat 
hippocampus, KCC2 expression was 
shown to accumulate on dendritic spine 
heads and at the origin of spines of CA1 
pyramidal cells, as well as on the thorny 
excrecences of CA3 pyramidal cells 
(Gulyas et al., 2001), which are known to 
be sites of intense excitation. In addition, 
KCC2 expression was more strongly 
expressed in interneuron types receiving 
stronger excitatory input, for example 
in parvalbumin-containing interneurons 
(Gulyas et al., 2001). A similar, but less 
pronounced, KCC2 expression profile 
was found in relay cells of rat thalamus 
(Bartho et al., 2004). In these cells, KCC2 
was mainly localized on the extrasynaptic 
membranes of thick and thin dendrites, 
which are the prime target of excitatory 
corticothalamic terminals (Bartho et al., 
2004). In addition, KCC2 was found on 
relay cell somata and in close association 
with excitatory synapses formed by 
cortical afferents (Bartho et al., 2004).
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expression pattern of NKCC1 mRNA, 
KCC2 transcripts show the opposite 
profile (Plotkin et al., 1997b;Rivera et 
al., 1999). In rat hippocampus, KCC2 
mRNA expression is minimal at birth, 
low during the fi rst postnatal week, and 
comparable with adults at P14-15 (Lu et 
al., 1999;Rivera et al., 1999).
KCC3. The expression of KCC3 mRNA is 
extensive in most adult rodent brain areas, 
such as cerebral cortex, hippocampus, 
brainstem, hypothalamus, cerebellum, 
white matter, chroid plexus, and piriform 
cortex (Pearson et al., 2001;Boettger et al., 
2003;Le Rouzic et al., 2006). The strongest 
KCC3 expression is, however, detectable 
in the highly myelinated tracts of the 
dorsal columns of spinal cord (Pearson et 
al., 2001). Interestingly, the development 
of myelin in rodent CNS correlates with 
the ontogeny of KCC3 (Pearson et al., 
2001), implying a possible role for KCC3 
in the physiology of myelination. In the 
PNS, KCC3 expression is observable 
in dorsal root ganglia (Pearson et al., 
2001;Boettger et al., 2003). In the prenatal 
rodent brain, KCC3 mRNA shows a low 
general expression level, but is slightly 
up-regulated until birth when expression is 
clear in the olfactory bulb, cortical plate, 
and spinal cord (Boettger et al., 2003).
KCC4. In the adult rat nervous system, 
KCC4 is present in both the CNS and 
PNS, with higher expression in the 
peripheral nerves and spinal cord than in 
the whole brain (Karadsheh et al., 2004). 
Within the brain, the cerebral cortex, 
hippocampus, and cerebellum display 
minimal KCC4 expression, whereas 
midbrain and brainstem demonstrate 
higher levels (Karadsheh et al., 2004). In 
the brainstem, however, KCC4 expression 
is restricted to the cranial nerves and 
nuclei such as facial (VII) nerve nucleus, 
abducens (VI) nerve, and vestibular (VIII) 
nerve (Karadsheh et al., 2004). In these 
cranial nerves, KCC4 is expressed in both 
neurons and oligodendrocytes (Karadsheh 
et al., 2004). In the spinal cord, KCC4 
is highly expressed in the white matter 
tracts of dorsal and ventral columns, but 
displays very low expression in the central 
gray matter (Karadsheh et al., 2004). 
In addition, KCC4 is expressed very 
strongly in the apical membrane of the 
choroid plexus and in the suprachiasmatic 
nucleus of the hypothalamus (Karadsheh 
et al., 2004;Le Rouzic et al., 2006). KCC4 
expression is high at birth but then declines 
throughout development (Karadsheh et al., 
2004).
The two orphan members of the CCC 
family, CIP1 and SLC12A8, are expressed 
in the brain as assessed by real-time 
quantitative PCR and Northern blot 
analyses (Caron et al., 2000;Hewett et al., 
2002). Unfortunately, no detailed analysis 
concerning the cell-specific expression 
patterns of these proteins is available.
1.3 Cation Cl- cotransporters and 
inhibitory neurotransmission
1.3.1 γ-Aminobutyric acid
The amino acids GABA and glycine 
serve as the predominant fast-acting 
inhibitory neurotransmitters in the adult 
mammalian nervous system. GABA was 
fi rst discovered in the mammalian brain 
over a half a century ago and was soon 
identifi ed as an inhibitory neurotransmitter 
in both vertebrate and invertebrate 
nervous systems (Owens and Kriegstein, 
2002). GABA is synthesized primarily 
from glutamate through enzymatic 
decarboxylation catalyzed by two glutamic 
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acid decarboxylase (GAD) enzymes, 
GAD65 and GAD67 (Erlander et al., 
1991), which are expressed only in neurons 
that use GABA as their neurotransmitter. It 
is estimated that only 10-20% of neurons 
are GABAergic in cortical circuits (Gulyas 
et al., 1999). However, these GABAergic 
interneurons form a dense network of 
synapses innervating the somata and 
dendrites of principal cells as well as other 
inhibitory interneurons, and thus play a 
major role in the generation of oscillations 
and other patterns of neuronal activity 
that are critical in major brain functions, 
such as memory and the sleep-wake cycle 
(Ben Ari and Holmes, 2005). GABA 
exerts its actions by interacting with 
ionotropic (GABA
A
) and metabotropic 
(GABA
B
) receptors (McKernan and 
Whiting, 1996;Couve et al., 2000;Korpi 
and Sinkkonen, 2006). 
Glycine receptors are ligand-gated 
ion channels comprised of fi ve subunits 
(Lynch, 2004). These receptors are found 
in many regions of the nervous system, 
but show particularly abundant expression 
in spinal cord and brain stem where 
they are involved in the control of motor 
rhythm generation, coordination of refl ex 
responses, and processing of sensory 
signals (Laube et al., 2002).
1.3.2 Maturation of γ-aminobutyric acid 
type A receptor-mediated transmission
Consistent with the critical role of GABA
A
 
receptors in CNS information processing, 
GABA
A
 receptor dysfunction is implicated 
in many pathological processes such as 
epilepsy, pain, and anxiety (Cherubini 
and Conti, 2001). The pentameric GABA
A
 
receptors are members of the ligand-
gated ion channel superfamily (Leite and 
Cascio, 2001), and characteristic of these 
receptors ligand binding is followed by 
a conformational change in the receptor 
complex that opens an integral ion 
channel. GABA
A
 receptors are comprised 
of diverse subunits (α1-α6, β1-β3, γ1-γ3, 
δ, θ, ε, π, and ρ1-ρ3), and native receptors 
usually consist of two α and two β subunits 
with an additional subunit, typically γ, 
δ, or ε (Whiting et al., 1999). Depending 
on the ion selectivity of a ligand-gated 
channel, fast neuronal depolarization 
or hyperpolarization results. In the case 
of ionotropic GABA
A
 receptors, the 
anion channel is permeant to Cl- and to 
a lesser extent to bicarbonate (HCO
3
-
) ions (Kaila and Voipio, 1987). Thus 
the electrochemical reversal potential of 
GABA
A
 receptors (E
GABA-A
) is set by the 
electrochemical gradients of Cl- and HCO
3
- 
ions across the transmembrane.
In most immature neurons, the 
activation of GABA
A
 receptors depolarizes 
the neuronal membrane potential, which 
can open voltage-gated Ca2+ channels and 
lead to a transient increase in intracellular 
Ca2+ concentration (Owens and Kriegstein, 
2002;Ben Ari, 2002). These depolarizing 
GABA responses have been observed in 
developing cells from many brain regions 
including neonatal rat hippocampus 
and Purkinje cells of the cerebellum 
(Leinekugel et al., 1995;Leinekugel et al., 
1997;Eilers et al., 2001), embryonic and 
early postnatal rat neocortex and spinal 
cord (Wu et al., 1992;Gao and Ziskind-
Conhaim, 1995;Owens et al., 1996;Maric 
et al., 2001), and early postnatal mouse 
hypothalamus (Wang et al., 2001;Gao and 
Van Den Pol, 2001). The early GABA-
mediated communication is believed 
to influence many Ca2+-dependent 
developmental processes such as cell 
proliferation, synaptogenesis and circuit 
formation (Ben Ari et al., 1994;Owens and 
Kriegstein, 2002;Fiszman and Schousboe, 
2004).
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The ionic basis for depolarizing 
GABA
A
 receptor-mediated responses 
depends on high [Cl-]
i
 levels and the 
resultant E
Cl
 that is more positive than 
the resting membrane potential (Ben Ari, 
2002). Thus, activation of the GABA
A
 
receptor results in Cl- effl ux and membrane 
depolarization. In immature neurons, the 
high internal Cl- is largely maintained 
by the action of the Cl--accumulating 
NKCC1 cotransporter, which shows robust 
expression in immature neurons during 
early postnatal development (Plotkin et 
al., 1997b;Sung et al., 2000;Yamada et al., 
2004;Dzhala et al., 2005). In contrast, the 
Cl--extruding KCC2 displays only minimal 
expression at this stage in rat cortical 
neurons and hippocampal pyramidal 
cells (Rivera et al., 1999;Dzhala et al., 
2005). The developmental shift in E
GABA-A
 
from depolarized levels towards more 
hyperpolarized potentials results from an 
ontogenetic decrease in [Cl-]
i
 (Luhmann 
and Prince, 1991;Owens et al., 1996). This 
is due to the developmentally up-regulated 
expression of functional KCC2 that results 
in increased neuronal Cl- extrusion (Lu et 
al., 1999;Rivera et al., 1999;Hubner et al., 
2001b).
The role for KCC2 in creating and 
maintaining the low neuronal [Cl-]
i
 was 
fi rst identifi ed by Rivera and collaborators, 
who showed that in functionally mature 
hippocampal  pyramidal  neurons, 
antisense oligonucleotide inhibition of 
KCC2 expression produced a marked 
positive shift in E
GABA-A
 and a consequent 
reduction or abolishment of normally 
hyperpolarizing GABA responses 
(Rivera et al., 1999). Consistent with 
this, deletion of the KCC2 gene results 
in mice that show signifi cantly increased 
depolarizing GABA responses in spinal 
cord motoneurons compared to wild-type 
control mice (Hubner et al., 2001b). These 
mice die immediately after birth due to 
abnormal muscle tonus, defects in motor 
control, and inability to breath (Hubner et 
al., 2001b). In addition, over-expression 
of KCC2 in immature neurons at an early 
developmental stage, when the protein is 
normally expressed at low levels, results 
in a substantial reduction in intracellular 
Cl- (Lee et al., 2005;Chudotvorova et al., 
2005;Fiumelli et al., 2005), and decrease 
or abolish GABA-elicited Ca2+ responses 
(Lee et al., 2005). Interestingly, this 
ectopic expression of KCC2 increases 
the number of GABA synapses and the 
frequency and amplitude of miniature 
postsynaptic potentials, suggesting that 
KCC2 may be involved in the regulation of 
the construction of GABAergic networks 
(Chudotvorova et al., 2005).
While KCC2 is considered as the 
major regulator of neuronal [Cl-]
i
 in the 
adult CNS, KCC3 seems to have a similar, 
but less pronounced, role (Boettger et al., 
2003). This is apparent in KCC3 knock-
out mice that display elevated [Cl-]
i
 and 
weakened, but still hyperpolarizing, 
GABA-responses as assessed in the 
cerebellar Purkinje neurons (Boettger et 
al., 2003).
1.3.3 γ-Aminobutyric acid type A 
receptor-mediated effects on membrane 
polarization
The ionotropic GABA
A
 receptor-mediated 
events have two effects on the postsynaptic 
membrane (Fig. 2). One is a shunting effect 
due to increased postsynaptic conductance 
that decreases the amplitude and duration 
of a voltage response generated by 
excitatory current (London and Hausser, 
2005). The time course for the shunting 
effect is limited to the opening time of 
GABA
A
 receptor (Staley and Mody, 1992). 
The second effect is due to the synaptic 
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‘battery’ to which the GABA
A
 receptor-
mediated conductance is connected, 
leading to depolarizing (excitatory) or 
hyperpolarizing (inhibitory) currents 
depending on the E
GABA-A
 value relative to 
the actual membrane potential. The time 
course for these GABAergic events outlasts 
the conductance change because the 
time constant of the membrane prolongs 
the depolarization or hyperpolarization 
of the membrane (Gulledge and Stuart, 
2003;Stein and Nicoll, 2003).
As already stated, in most mature 
neurons the intracellular Cl- is low due to 
Cl- extruding activity of KCC2 (Rivera 
et al., 1999), and consequently the E
Cl
 is 
more negative than the resting membrane 
potential (~-65 mV). Thus GABA
A
 
receptor activation typically results in 
net entry of Cl- ions, and the classically 
described hyperpolarizing postsynaptic 
potentials (IPSPs). The GABA
A
 receptor 
is, however, permeable to HCO
3
- ions as 
well (the permeability ratio for HCO
3
- to 
Fig. 2. Different roles for KCC2 activity in tonic and phasic GABAergic neurotransmission. 
A) Illustrated is a simplifi ed neuron receiving simultaneous excitatory and inhibitory 
inputs at a dendritic location. A presynaptic release of glutamate (black circles) activates 
synaptic glutamate receptors causing an inward postsynaptic current. Simultaneous 
presynaptic release of GABA activates those postsynaptic GABAA receptors that are 
clustered in the membrane immediately beneath the release site. Chloride extrusion 
by the activity of KCC2 results in reversal potential for GABAA receptors (EGABA-A) that 
is more negative than the resting membrane potential (Vm). Thus phasic activation of 
synaptic GABAA receptors results in net entry of Cl
- ions, and the classic hyperpolarizing 
postsynaptic potential. The GABAA receptor is also permeable to bicarbonate (HCO3
-) ions 
(the permeability ratio for HCO3
- to Cl- ions being approximately 0.25). The equilibrium 
potential for HCO3
- is more positive than Vm and thus the direction of HCO3
- ion fl ux 
results in outwardly directed (depolarizing) current. Therefore, the reversal potential of 
GABAA receptor-gated currents is determined by the electrochemical gradients of Cl
- and 
HCO3
-. In this case, the internal concentration of Cl- is so low that EGABA-A remains more 
negative than the resting membrane potential, despite the depolarizing HCO3
- current. 
The GABAA receptor-mediated effect on the postsynaptic membrane occurs by both 
the shunting effect and the hyperpolarization of the membrane. The time course for 
these GABAergic events outlasts the conductance change because the time constant 
of the membrane prolongs the depolarization or hyperpolarization of the membrane. B) 
Illustrated is a similar neuron receiving an excitatory input at a dendritic location (spine). 
A release of glutamate activates glutamate receptors causing an inward postsynaptic 
current that spreads to the soma. A low concentration of ambient GABA (white circles) 
tonically activates high-affi nity GABAA receptors at extrasynaptic locations, through 
which depolarizing current leaks out (shunting). In these cells, ECl may be at equilibrium 
(or even above the resting membrane potential) due to low KCC2 activity. If ECl is at 
equilibrium (as shown in B), GABA is depolarizing due to the contribution of HCO3
- 
ions to the ion fl ux mediated by GABAA receptors, making EGABA-A more positive than 
ECl. EGABA-A may or may not be close the resting membrane potential, but is below the 
threshold potential for action potential (AP) generation. Thus the increase in membrane 
conductance (shunting) through the tonic extrasynaptic GABAA receptors always inhibits 
the depolarized membrane potential from reaching the action potential threshold, 
and the shunting is effective even if EGABA-A is above the Vm and GABA responses are 
depolarizing.
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Cl- being approximately 0.25) (Bormann 
et al., 1987). In contrast to E
Cl
, the E
HCO3
 is 
more positive than the resting membrane 
potential (around -10 mV), and hence the 
driving force is signifi cantly stronger for 
HCO
3
- than for Cl- at the resting membrane 
potential. Thus in some mature neurons, 
even in the presence active Cl- extruding 
mechanism, GABAergic neurotransmission 
can be depolarizing under basal conditions 
due to the contribution of HCO
3
- ions to 
the ion flow through GABA
A
 receptors, 
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thereby making E
GABA-A
 in some cases 
more positive than E
Cl
 (Kaila et al., 1993).
The depolarizing GABA responses 
can still be inhibitory due to the shunting 
mechanism. However, the effect of 
shunting depends on its timing and 
location in relation to excitatory inputs and 
occurs when the conductance change is 
temporally or spatially nonseparated from 
excitatory inputs (Gulledge and Stuart, 
2003). The timing of shunting inhibition 
is important because the depolarizing 
GABA responses have a longer time 
course than the underlying conductance 
change. Therefore, if the depolarizing 
GABA conductance occurs near (± 2 ms) 
the onset of excitatory input, the GABA 
response will first be inhibitory due to 
conductance change and then excitatory 
due to depolarized membrane potential 
which has not yet decayed back to rest. 
If the shunting GABA conductance is 
temporally separated from the excitatory 
stimulation by several milliseconds, the 
shunting conductance change may be 
over before the excitatory input and no 
inhibition of the excitation occurs.
When the shunting conductance 
and excitatory inputs are temporally 
coincident, the spatial relation of these 
inputs determines whether GABA 
is excitatory or inhibitory. If GABA 
applications to dendritic locations are 
paired with excitatory subthreshold 
somatic or more proximal dendritic 
depolarizations, the effect of GABA 
(measured in soma) is purely excitatory. 
This is because the GABA-induced 
membrane depolarization, in contrast to 
the GABA-induced conductance increase, 
will spread electrotonically to the soma. 
However, if the dendritically applied 
GABA is paired with suprathreshold 
excitatory inputs located at more distal 
dendritic sites than the GABA application 
site, the GABA response will inhibit the 
generation of action potential by shunting. 
Similarly, somatic GABA responses that 
are coincident with somatic or dendritic 
excitatory inputs are inhibitory (Gulledge 
and Stuart, 2003).
1.3.4 Phasic and tonic activation of 
γ-aminobutyric acid type A receptors
Ionotropic GABA
A
 receptors mediate two 
spatially and temporally distinct modes 
of inhibition (Fig. 2); ‘phasic’ fast and 
transient inhibitory postsynaptic currents 
at synapses following presynaptic release 
of vesicular GABA, and continuous 
‘tonic’ conductance at extrasynaptic sites 
activated by low ambient concentrations of 
extracellular GABA (Farrant and Nusser, 
2005). The classic phasic form of GABA
A
 
receptor activation is characterized 
by hyperpolarizing IPSPs, which are 
dependent on the KCC2 activity. Synaptic 
GABAergic inhibition is generally 
thought to play an important role in 
several basic physiological processes of 
the CNS, including prevention of neuronal 
overexcitability as well as the regulation 
and synchronization of the neuronal 
network activity (Cherubini and Conti, 
2001).
In contrast to the transient (phasic) 
form of GABAergic inhibition, the tonic 
form of GABA inhibition is mediated by 
extrasynaptic GABA
A
 receptors (Farrant 
and Nusser, 2005). These receptors mediate 
their inhibitory effects predominantly 
through the shunting mechanism (Brickley 
et al., 1996;Mitchell and Silver, 2003). 
Tonic GABAergic currents are critically 
involved in the regulation of neuronal 
network excitability (Semyanov et 
al., 2003) and information processing 
(Mitchell and Silver, 2003;Chadderton et 
al., 2004), and have been identifi ed from 
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several brain regions, including cerebellar 
granule cells (Kaneda et al., 1995;Brickley 
et al., 1996;Wall and Usowicz, 1997), 
hippocampal interneurons, pyramidal cells, 
and dentate granule neurons (Semyanov 
et al., 2003;Stell et al., 2003;Yeung et al., 
2003;Wei et al., 2004;Caraiscos et al., 
2004), and thalamic neurons (Belelli et al., 
2005;Cope et al., 2005).
The subunit composition of GABAA 
receptors determines not only the 
pharmacological properties and function 
of the receptors, but also distribution 
within the cellular membrane (Korpi et 
al., 2002a). For example, receptors that 
contain the benzodiazepine-sensitive γ2 
subunit are preferentially located in the 
synapses, whereas the δ subunit is present 
predominantly in extrasynaptic receptors 
(Somogyi et al., 1996;Nusser et al., 1998). 
The δ subunit GABAA receptors have a 
highly specifi c regional distribution and 
are the major contributors to the tonic 
GABA current in the cerebellar and 
dentate granule cells as well as in thalamic 
neurons (Brickley et al., 1996;Pirker et 
al., 2000;Nusser and Mody, 2002;Stell et 
al., 2003;Belelli et al., 2005;Cope et al., 
2005). In the cerebellar granule cells, the 
δ subunit is intimately associated with the 
α6 subunit (Jones et al., 1997;Nusser et 
al., 1999), whereas in the dentate granule 
cells it probably associates with the α4 
subunit (Sur et al., 1999a). In hippocampal 
pyramidal neurons, tonic inhibition has 
been reported to be mediated primarily 
by extrasynaptic α5 subunit-containing 
GABAA receptors (Caraiscos et al., 2004), 
whereas in CA1 interneurons at least 
part of the tonic current is mediated by 
γ subunit-containing GABAA receptors 
(Semyanov et al., 2003).
1.3.5 Cation-Cl- cotransporter isoform 2 
and epilepsy
Epilepsy is a chronic neurological 
disorder that affects approximately 1-
2% of the population worldwide. The 
disease is characterized by recurrent 
spontaneous seizures which are the clinical 
manifestation of an underlying transient 
abnormal neuronal activity (Steinlein, 
2004). This hyperactivity is conventionally 
thought to occur when there is imbalance 
between neuronal  excitat ion and 
inhibition, where glutamate and GABA, 
respectively, play important roles. This 
view is, however, an oversimplifi cation as 
the GABA-mediated neurotransmission 
cannot be described as purely ‘inhibitory’, 
as discussed above (1.3.3). In addition, 
GABAergic interneurons are heterogenous 
and have many roles that are not 
restricted to the straightforward concept 
of ‘inhibition of the target’ (Freund, 
2003;Cossart et al., 2005). Defects 
in the GABAergic neurotransmission 
system do, however, contribute to the 
synchronous hyperexcitable activity of 
the epileptic brain. This is confi rmed by 
the effectiveness of anticonvulsant drugs 
which enhance GABAergic transmission, 
and by in vitro studies using cortical slices 
in which the application of GABA blockers 
causes the appearance of epileptiform 
discharges.
In epileptic tissue, modif ications 
to the GABAergic system take place at 
various levels within the GABAergic 
networks. These modifi cations may include 
changes in GABA
A
 receptor subunit 
composition and selective loss of some 
GABAergic interneuron types (Cossart et 
al., 2005;Magloczky and Freund, 2005). 
Recently, depolarizing GABA
A
 receptor-
mediated transmission has been described 
as one of the potential mechanism 
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contributing to the pathophysiology 
of epilepsy (Cohen et al., 2002). In 
hippocampal-subicular preparations 
obtained from mesial temporal lobe 
epilepsy patients, spontaneous synchronous 
events could be observed in the subiculum 
(Cohen et al., 2002). These discharges 
were dependent on both glutamatergic and 
GABAergic transmission, and the network 
of neurons discharging during population 
events comprised subicular interneurons 
and a subgroup of pyramidal cells. The 
pyramidal cells displayed depolarizing 
rather than hyperpolarizing actions of 
GABA (Cohen et al., 2002), suggesting 
that in this context, GABA may serve a 
pro- rather than an anti-epileptic role. The 
depolarizing GABA responses in subicular 
pyramidal cells were presumably due 
to reduction in KCC2 levels which thus 
lead to accumulation of Cl- and enhanced 
neuronal excitability. Indeed, the role of 
KCC2 in the pathophysiology of epilepsy 
has been confirmed in KCC2-deficient 
mice that retain 5-8% of the protein, as 
these mice exhibit frequent seizure activity 
and severe brain injury (Woo et al., 2002). 
In addition, hippocampal kindling-induced 
seizures in vivo and interictal-like activity 
in slices lead to brain-derived neurotrophic 
factor (BDNF)-mediated down-regulation 
of KCC2 mRNA in rodents (Rivera et al., 
2002;Rivera et al., 2004). Interestingly, in 
slice preparations of chronically injured 
epileptogenic neocortex, Cl- transport can 
be largely altered with only minor changes 
in resting E
GABA-A
 (Jin et al., 2005), 
suggesting that impaired Cl- extrusion 
due to reduced KCC2 may be suffi cient to 
maintain [Cl-]
i
 under resting conditions but 
not during periods of intense GABAergic 
interneuron activity that might occur at 
seizure discharge.
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2. AIMS OF THIS STUDY
The aims of this thesis were to understand the physiological role of KCC2 in vivo by 
producing transgenic KCC2-defi cient mice and analyzing the biological consequences 
of the gene-defi ciency. Another aim was to elucidate the role for different CCC family 
members in the regulation of CNS development by analyzing the expression patterns of 
KCC1-4 and NKCC1 in the rodent brain during embryonic development.
The specifi c aims were to:
1. To reveal the expression patterns of NKCC1, KCC1, KCC2, KCC3, and KCC4 
in the rodent CNS during embryonic development.
2 To produce mice with genetically inactivated or down-regulated expression of 
KCC2.
3 To investigate the significance of reduced KCC2 levels on adult mouse 
behavior.
4 To study the requirements for KCC2 in tonic versus phasic GABA
A
 receptor-
mediated inhibition in the adult CNS in vivo.
Aims of the Study
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3. MATERIALS AND METHODS
The methods used have been described in 
more detail in the respective publications 
(I-IV)
3.1 Generation of cation-Cl- 
cotransporter isoform 2-defi cient mice 
(I, III, IV)
Generation of KCC2-deficient mice is 
described in detail in (I). Briefly, the 
mutant allele-producing gene targeting 
vectors were developed by utilizing an in 
vitro DNA transposition-based technique. 
For the KCC2 null allele, a neomycin 
phosphotransferase (neo) resistance gene 
cassette was inserted into exon 4 of the 
Slc12a5 gene to disrupt the reading frame, 
whereas in the KCC2 hypomorphic allele, 
a reversely directed neo cassette was 
introduced into intron 3. Both mutant 
alleles were generated in R1 embryonic 
stem cells, and chimeric mice derived from 
these cells were bred to wild-type C57BL/
6JOlaHsd and 129S2/SvHsd female 
mice (Harlan) to obtain F1 heterozygotes 
(KCC2wt/null and KCC2wt/hy). For the fi rst 
characterization of the mutation, KCC2null/
null, KCC2hy/hy and wild-type littermates 
were established from matings of F1 
KCC2wt/null and KCC2wt/hy mice, respectively 
(I, III). Thereafter, heterozygous KCC2wt/
hy and KCC2wt/null were backcrossed to 
wild-type C57BL and 129S2 mice for at 
least fi ve generations. Intercrossing of the 
KCC2wt/hy (in C57BL/6) and KCC2wt/null (in 
129S2) produced heteroallelic KCC2hy/null, 
heterozygous KCC2wt/null and KCC2wt/hy, as 
well as wild-type littermates in a (C57BL6 
x 129S2)F1 hybrid background (Banbury 
conference on genetic background in 
mice, 1997) that were used in (III, IV). 
The animals were kept on a normal day 
and night cycle (lights on 07.00, off 19.00 
h) and were given free access to food 
and water. The experimental protocols 
were approved by the committee for 
Animal Experiments of the University of 
Helsinki.
3.2 In situ hybridization (I)
The protocol for in situ hybridization 
analyses is described in the original 
article and references therein (II), probes 
are depicted in table 2. In experiments 
where embryonic tissues were used (II, 
III), the animals were mated overnight 
and inspected the following morning for 
a vaginal plug to confi rm copulation. The 
day of plug confi rmation was regarded as 
E0.5.
3.3 Reverse transcriptase-polymer chain 
reaction (I, III)
The protocols for total extraction of 
mRNA from mouse brain and the PCR 
amplifi cation for semiquantitative reverse 
transcriptase-polymer chain reaction 
(RT-PCR) analysis are described in (II, 
III). The PCR primers used for relevant 
purposes are listed in table 3.
3.4 Immunohistochemistry and Western 
blotting (I, II, III)
The procedures for both immuno-
histochemistry (IHC) and Western 
blotting (WB) are described in (I, 
II, III). The antibodies used in both 
procedures are presented in table 4. In 
the immunohistochemical analysis of 
embryonic rat brain, antibodies against the 
vimentin and the class III β-tubulin (βIII) 
TUJ1 were used as specific markers to 
detect radial glia and postmitotic neurons, 
respectively. T4 monoclonal antibody was 
used to detect NKCC1 expression in both 
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Table 2. List of probes used for in situ hybridization
Table 3. List of primers used for RT-PCR quantifi cation
Probe Primers Product bp Used in 
Mouse KCC1 5’-TCGGGACCAGTTTGACATCT-3’ 
5’-CGATGTCAGCCACCACATAC-3’C 
301 III
Mouse KCC3 5’-GCAGTGAGGTCATCACCATTT-3’ 
5’-TGGAATCCCCTTAGTTCAGC-3’ 
700 II, III 
Mouse KCC4 5’-CATGCCCACGAACTTTACG-3’ 
5’-TTCTTCCCCTCGAAGTAGCTC-3’ 
203 III
Mouse cyclophilin 5’-GGTCAACCCCACCGTGTTCTTCGACAT-3’ 
5’-GGACAAGATGCCAGGACCTGTATGCT 
294 II
Mouse GAPDH 5’-GCAAAGTGGAGATTGTTGCCAT 
5’-CCTTGACTGTCGCGTTGAATTT 
150 III
Materials and Methods
Probe Accession/source Nucleotides Insert bp Region 
Mouse KCC1 AA185691 (EST) 3295-3746 495 3’-UTR 
Mouse KCC2 AA982489 (EST) 4605-5566 1039 3’-UTR 
Rat KCC2 Payne et al., 1996 5-834 830 3’-UTR 
Mouse KCC3 BF020529 (EST) 2832-3348 682 3’-CDR 
Mouse KCC4 AI592647 (EST) 2508-3248 745 3’-CDR 
Mouse KCC4 RT-PCR 72-275 203 5’-UTR 
Mouse NKCC1 AA980272 (EST) 3498-4346 964 3’-CDR+ UTR 
Mouse NKCC1 RT-PCR 2742-3006 265 CDR
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immunohistochemistry and WB. KCC2-
specifi c antibodies were used to evaluate 
the KCC2 protein levels and distribution in 
wild-type and KCC2 mutant mice by WB 
and immunohistochemistry. Antibodies 
against parvalbumin, synaptophysin, and 
calbindin were used to evaluate the gross 
morphology of the KCC2hy/null mouse brain. 
The neurofi lament H and neuron-specifi c 
class of III β-tubulin specifi c-antibodies 
were used as loading controls in WB.
3.5 Mouse behavioral studies (III, IV)
The behavioral testing is described in 
detail in the respective publications (III, 
IV), except for the previously unpublished 
prepulse inhibition (PPI). General 
characteristics of some key experimental 
Table 4. Primary antibodies used in immunohistochemistry and Western blotting
Primary antibody Host/Antibody Source/Ref. Dilution Method Used in 
KCC2 Rb polyclonal 
Rb polyclonal 
Williams et al. 
1999 
1:2000 
1:200
WB
IHC
I
III
Neurofilament H Rb polyclonal NA1211, Affiniti 1:2000 WB I 
Class III β-tubulin (βIII) Mo monoclonal Clone TUJ1, 
BABCO
1:5000 IHC II 
NKCC1, clone T4 Mo monoclonal Hybridoma Bank, 
University of Iowa 
1:1000 
1:2000 
IHC
WB
II
III
βIII Rb polyclonal BABCO 1:2000 
1:1000 
IHC
WB
II
III
vimentin Rb polyclonal Sigma 1:20 IHC II 
parvalbumin Rb polyclonal Swant 1:400 IHC III 
calbindin Rb polyclonal Swant 1:400 IHC III 
synaptophysin Rb polyclonal Zymed 1:50 IHC III 
setups used in this thesis are discussed 
below.
3.5.1 Elevated plus-maze
The elevated plus-maze is a nonshock, 
unconditioned, and natural confl ict model 
of anxiety-related behaviors (Lister, 
1990). The test apparatus consists of two 
open arms and two arms that are enclosed 
by high walls (Handley and Mithani, 
1984;Pellow et al., 1985). The elevated 
plus-maze rests on the conflict between 
the tendency of mice to explore a novel 
environment and the aversive properties of 
a high and open area, which is manifested 
in the typical behavior of mouse in the 
model: greater exploration of the closed 
arms and less exploration of the open arms 
(Handley and Mithani, 1984;Pellow et al., 
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1985;Lister, 1987). Advantages of the 
plus-maze test are that it is an effi cient and 
simple test which does not involve lengthy 
training as it is based on spontaneous 
animal behavior. In addition, the total 
number of entries into all arms provides 
a built-in control measure for general 
hyperactivity or sedation (Crawley, 2000). 
The disadvantage of the model is the non-
continous arrangement of the arms. This is 
apparent when the mice stay in the central 
start box and may repeatedly return to the 
start box rather than fully enter an arm 
(Crawley, 2000).
3.5.2 Open fi eld
The open f ield test consists of the 
measurement of behaviors elicited 
by placing a mouse in a novel, wall-
sur rounded arena (either circular, 
square, or rectangular) (Walsh and 
Cummins, 1976). These behaviors involve 
spontaneous motor activity and behaviors 
related to emotionality, and are elicited by 
a variety of factors such as the removal of 
the animal from a familiar environment, 
exposing the mouse to the test 
environment, and prior experience of the 
test situation (Walsh and Cummins, 1976). 
Motor activity is evaluated by calculating 
the overall locomotion score, whereas the 
emotional (e.g. anxiety, fear) behavior is 
generally measured by monitoring the time 
the animal spends in the central part, the 
latency to enter the central part, grooming 
activity, or rearing activity (Archer, 
1973;Crawley et al., 1997;Belzung, 1999). 
Differences in the experimental setup of 
the test apparatus (e.g. light illumination, 
background noise, fi eld size) as well as the 
genetic background of the animals may 
have an effect on the animal performance 
(Walsh and Cummins, 1976;Crabbe, 
1986;Mathis et al., 1994).
3.5.3 Rotarod
Performance on the rotarod measures 
the ability of an animal to remain on a 
rotating rod. As motor performance is a 
behaviorally complex phenomenon, the 
rotarod task may require the animal to 
employ not only motor coordination and 
sensorimotor control, but also vision, 
balance, adequate muscle strength, and 
attention (Jones and Roberts, 1968;Crabbe 
et al., 2005). In addition, for rotarod tasks 
where multiple trials are given, motivation 
and ability to learn and remember may 
be critical factors (Crawley, 2000;Crabbe 
et al., 2005). After practice, motor 
performance becomes a more automatic, 
unconscious behavior, which is controlled 
by motor cortex and divisions of the basal 
ganglia and cerebellum (Hikosaka et 
al., 2002). In accelerating rotarods, the 
rotational speed gradually increases, and 
thus requirements for the mouse to stay on 
the rod gradually increase. The duration of 
the test may affect the animal performance, 
as a 5 min test period may have a fatiguing 
effect on the animal.
3.5.4 Water maze
The Morris water maze is used to evaluate 
spatial learning and memory of rats and 
mice (Morris, 1981). The experimental 
setup consists of a pool of water (22-23°C) 
and a hidden escape platform submerged 
beneath the surface. The task requires 
spatial navigation as mice are required 
to learn the location of the platform by 
using visual cues that surround the maze 
(Morris, 1981). Platform fi nding is based 
on the principle that rodents are highly 
motivated to escape from the water by the 
quickest, most direct route. Disadvantage 
of the model is that some rodent strains 
enjoy swimming, whereas some strains 
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sink rather than swim (Crawley, 2000). 
Transfer tests (probe trials) reveal whether 
animals are using a spatial search strategy 
to locate the platform (Morris, 1981).
Performance on the task is highly 
infl uenced by the genetic background of the 
animal (Upchurch and Wehner, 1989;Owen 
et al., 1997). For example, within some 
inbred mouse strains one substrain may 
perform well on the task, whereas some 
other substrain performs poorly in the 
task (Montkowski et al., 1997;Balogh 
et al., 1999). The motivational factors as 
well as perceptual and motor abilities also 
influence the water maze performance 
(Lipp and Wolfer, 1998). In addition, mice 
that display enhanced anxiety may be 
more sensitive to the stressful component 
of the swimming task, or may alternatively 
display reduced problem-solving abilities 
or memory (Morley et al., 2001;Herrero 
et al., 2006). These confounding factors 
may be controlled by testing the animals 
in the visible platform version of the 
Morris water maze task. In this variant, 
the escape platform is made visible by a 
colored marker directly above the escape 
platform, and this serves as a useful 
control of any impairments seen in the 
hidden platform version (Morris, 1981). 
Finally, possible hypothermia caused by 
the exposition of animals to water may 
affect the swimming speed of the mice 
(Panakhova et al., 1984;Rauch et al., 
1989). This problem can be alleviated by 
increasing the intertrial interval time, as 
demonstrated in mice by increasing the 
intertrial interval from 30s to 13 min. The 
cooling effect observed with 30s intervals 
was removed when the intertrial interval 
time was increased to 13 min (Iivonen et 
al., 2003). In the experimental setup used 
in this thesis, the intertrial interval was 
approximately 3 min. During this time 
the animals were able to dry themselves 
and, consequently, no evidence of slowing 
down the swimming speed was observed. 
No additional control of body temperature 
was used.
3.5.5 Hot plate, tail withdrawal, and von 
Frey hairs
The hot plate test measures thermal pain 
reflexes due to footpad contact with a 
heated surface. The mouse is placed on a 
horizontal surface heated to 52-55ºC and 
the latency to lift and lick the paws is the 
measure of pain sensitivity or analgesia. 
The refl ex measured by the hot plate test 
requires intact circuitry in the brain as well 
as in the spinal cord (Malmberg, 1999).
Tail withdrawal (hot-water tail fl ick) 
measures a spinal refl ex and the dependent 
variable is the latency for the mouse to 
withdraw the tail when immersed in a 
beaker of water maintained usually at 
52.5ºC (Gonzales-Rios et al., 1986;Hole 
and Tjolsen, 1993).
Von Frey hairs are a set of very fi ne 
gauge calibrated metal or nylon fi bers used 
to measure the sensitivity of the mouse for 
mechanical stimulus (Fruhstorfer et al., 
2001). The experimental setup includes 
an elevated platform, of which the surface 
is a wide gauge wire mesh. The mouse 
is placed on the mesh and the von Frey 
hair is inserted from below to poke the 
plantar surface of the hindpaw (Pitcher 
et al., 1999). When a straight elastic fi ber 
of constant diameter is pressed vertically 
against the skin, the force it exerts on the 
skin grows until the fi ber starts bending. 
Once bent, the vertical force remains fairly 
constant even if the fi ber is bent further. 
Applying hairs of different force is done 
to establish the paw withdrawal threshold 
(Fruhstorfer et al., 2001). Pain sensitivity 
in rodents is affected by stress (Lewis 
et al., 1980;Calcagnetti and Holtzman, 
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1990). The confounding effects of novelty 
and handling stress can be avoided by prior 
handling of the animals and habituation to 
the test environment (Crawley, 2000).
3.5.6 Prepulse inhibition (unpublished 
data)
Prepulse inhibition (PPI) is a cross-species 
measure of sensorimotor gating, which 
is the ability of a weak sensory event 
to inhibit “gate” the motor response to 
an intense sensory stimulus (Swerdlow 
et al., 2001). Deficits in PPI have been 
associated with a number of psychiatric 
diseases, including schizophrenia (Braff et 
al., 2001).
A group of 3-5-month-old littermate 
mice (29 wild-type males, 24 KCC2hy/
null males, 28 wild-type females, 32 
KCC2hy/null females) was subjected to a 
PPI experiment, which was performed 
in MED Associates (St. Albans, VT, 
USA) chambers. The isolation chambers 
contained a transparent acrylic cylinder 
(4.5 cm diameter, 10 cm length) for 
restraining the animal on the platform. 
The restrainer was placed on a platform 
containing a movement-sensitive load cell 
that produces a voltage when the mouse’s 
movements are transmitted through the 
restrainer bottom. The resulting acoustic 
startle response or prepulse inhibition 
data is the displacement of the load cell 
(as expressed in Volts). A fan and a red 
light were provided inside the chamber 
for the comfort of the animal while inside 
the enclosed chamber. Data acquisition 
was performed using Med Associates 
software.
Mice were placed in the startle 
chamber with a background white noise of 
65 dB and left undisturbed for 5 minutes. 
Testing was performed in 12 blocks of 5 
trials and 5 trial types were applied. One 
trial type was a 40 ms, 105 dB white noise 
acoustic startle stimulus presented alone. 
This was used as the measure of baseline 
startle-sensitivity. In the remaining 4 trial 
types the startle stimulus was preceded by 
the acoustic prepulse. The 20 ms prepulse 
stimuli were white noise bursts of 68, 72, 
76 and 80 dB. The delay between onsets 
of prepulse stimuli and startle stimuli was 
100 ms. The 1st and 12th block consisted 
of startle stimulus-alone trials. In the 
remaining blocks the startle stimulus and 
prepulse stimulus-plus-startle stimulus 
trials were presented in pseudorandomized 
order such that each trial type was 
presented once within a block of 5 trials. 
The intertrial interval ranged between 10 
and 20 seconds and experiment lasted 30 
min per animal. The startle response was 
recorded for 65 ms starting with the onset 
of the startle stimulus. The maximum 
startle amplitude recorded during the 65-
ms sampling window was used as the 
dependent variable. The startle response 
was averaged over 10 trials from blocks 
2-11 for each trial type. The PPI for each 
prepulse stimulus was calculated using the 
following formula: 100-[(startle response 
on prepulse stimulus-plus-startle stimulus 
trials / startle response on startle stimulus 
trials) x 100].
3.6 Electrophysiology (IV)
Electrophysiological recordings from acute 
hippocampal slices using whole-cell- and 
perforated-patch confi gurations were done 
as described in (IV).
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4. RESULTS AND DISCUSSION
4.1 Expression of cation-Cl- 
cotransporter isoforms in the 
developing CNS (I)
In order to elucidate the possible roles 
for CCC isoforms in the control of CNS 
development, we conducted an analysis of 
the distribution patterns of KCC1-4 and 
NKCC1 in rodent CNS during embryonic 
development using immunohistocemistry 
and in situ hybridization. Results from 
this analysis (I) and other equivalent 
reports are summarized in table 5. 
The developmental stages (E12.5-P1) 
presented in the table 5 correspond to 
the embryonic mouse development. 
The rat nervous system development is 
about two days behind from the mouse 
during the second week of gestation, and 
about three to four days behind at birth 
(Alvarez-Bolado and Swanson, 1996). In 
table 5, results from the developing rat 
nervous system have been extrapolated 
to match the mouse developmental stage 
(e.g. E14.5 in rat corresponds to the 
mouse developmental stage at E12.5 in 
mouse). The developmental time period 
in mouse (E12.5-P0) corresponds roughly 
to the human developmental time window 
spanning the late 1st semester and the 
early 2nd semester (Clancy et al., 2001).
4.1.1 Na+-K+-Cl- cotransporter isoform 
1 is highly expressed in the proliferative 
zones of subcortical regions
NKCC1 transcripts were detectable in 
the developing mouse CNS already at 
E12.5, when a moderate expression 
was observed in the developing 
choroid plexus invagination and in the 
proliferative ventricular zones (VZs) 
where neurogenesis takes place, including 
the the lateral ganglionic eminence of 
the telencephalon. By E14.5 in mouse, 
NKCC1 mRNA expression had increased 
signifi cantly in the telencephalon and was 
robust in the VZs of lateral and medial 
ganglionic eminences, and moderate 
in the VZ of isocortex. At this stage, 
NKCC1 mRNA expression was not 
detectable in the cortical plate (CP) layer 
or in the subventricular zone. A moderate 
expression of NKCC1 transcripts was 
detected throughout the ventricular layers 
of the developing embryo (table 5). As 
indicated by the general co-localization 
of NKCC1 protein with radial glia 
marker vimentin, the majority of NKCC1 
expressing cells in the VZ layers were 
radial glia and neuronal precursor cells. 
Towards later stages of embryonic 
development (E17-P0), NKCC1 mRNA 
expression disappeared from the VZ layers 
and shifted to the CP layer where the 
transcripts were expressed in postmitotic 
migrating or differentiating neurons. 
Throughout embryonic development, 
NKCC1 expression was strong in the 
choroid plexus.
Our results of embryonic rodent 
NKCC1 expression were consistent with 
other reports (Hubner et al., 2001a;Wang 
et al., 2002), which demonstrated strong 
NKCC1 expression in the embryonic 
choroid plexus and premature cells of 
neuroepithelia.
4.1.2 Cation-Cl- cotransporter isoform 2 
expression follows neuronal maturation
The expression of KCC2 mRNA was 
first apparent in the ventral part of 
the cervical spinal cord at E12 in rat 
embryos. Thereafter, KCC2 expression 
gradually spread in caudal-rostral 
progression following the pattern of 
neuronal maturation, as indicated by the 
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coexistence of KCC2 mRNA with TUJ1 
(class III β-tubulin) labeled brain regions. 
Interestingly, in newly differentiated 
regions most TUJ1 expressing cells were 
KCC2-negative, suggesting that KCC2 is 
not expressed in immature, newly born 
neurons.
In E14.5 rat embryos, KCC2 
t r a n s c r i p t s  w e r e  a b u n d a n t  i n 
rhombencephalon, diencephalon, and 
basal ganglia. At this developmental 
stage, these brain regions are known to 
contain postmitotic neurons (Altman and 
Bayer, 1995). In the diencephalon, KCC2 
mRNA was high in ventral thalamus, 
ventral lateral geniculate complex, lateral 
hypothalamic area, and in the subthalamic 
nucleus. Especially high levels of KCC2 
expression were detected in the olfactory 
bulb and the lower parts of the brainstem; 
the tegmental region of medulla and the 
caudal part of the spinal nucleus of the 
trigeminal nerve, consistent with the more 
advanced maturation of neurons in these 
regions (Altman and Bayer, 1995). In P0 
rat brain, KCC2 expression was spread 
over the complete spinal cord and was 
present in all parts of the brain except for 
cortex and hippocampus.
In conclusion, consistent with other 
reports (Clayton et al., 1998;Rivera et al., 
1999;Hubner et al., 2001b;Wang et al., 
2002;Stein et al., 2004), the up-regulation 
of KCC2 mRNA expression in the rodent 
brain during embryonic development 
follows the neuronal maturation in all 
CNS regions.
4.1.3. Cation-Cl- cotransporter isoforms 
1 and 3 exhibit low expression in the 
embryonic brain
The expression of KCC1 mRNA in the 
embryonic mouse brain was generally low 
and displayed a slight up-regulation over 
the course of development, consistent with 
a previous report (Clayton et al., 1998). 
However, inconsistent with the in situ 
hybridization report from (Wang et al., 
2002), we did not observe a strong KCC1 
mRNA expression in the prenatal cortical 
plate, cerebral cortex hippocampus, or 
caudate putamen. At E14.5 in mouse 
brain, we detected strong KCC1 mRNA 
expression only in the choroid plexus.
KCC3 mRNA expression was 
generally weak in the early embryonic 
rodent brain. At E14.5 in mouse, KCC3 
mRNA was detectable in diencephalon, 
mesencephalon, and rhombencephalon, 
and in the newly differentiated regions of 
the preplate layer of telencephalon where 
postmitotic neurons organize into layers. 
KCC3 mRNA expression in the brain was 
moderately up-regulated at later stages of 
development and displayed an increase 
in the cortex and strong signal in the 
olfactory bulb in the P0 embryonic brain. 
The observed developmental up-regulation 
of KCC3 mRNA expression is consistent 
with another report (Boettger et al., 2003), 
demonstrating minimal expression of 
KCC3 in the E14.5 mouse embryo and 
strong expression in mouse P0 brain.
4.1.4 Cation-Cl- cotransporter isoform 
4 expression is high in the proliferative 
zones
T h r o u g h o u t  e m b r y o n i c  m o u s e 
development, KCC4 mRNA expression 
was abundant in the subcortical 
proliferative zones where neurogenesis 
occurs. In the E14.5 mouse embryo, KCC4 
transcripts were strongly expressed in the 
ventricular layers of telencephalon and 
rhombencephalon, and moderately in the 
VZs of diencephalon and mesencephalon. 
In contrast, no KCC4 was detectable in the 
intermediate zones and the preplate of the 
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isocortex. In addition, moderate expression 
was observed in the spinal nucleus of the 
trigeminal nerve of the rhombencephalon 
and in the dorsal roof plate of the brain 
stem in the E14.5 mouse embryo. In 
contrast to other KCCs, KCC4 mRNA was 
expressed in the peripheral ganglia, such 
as the vestibular (VIII) ganglion. Towards 
P0, KCC4 mRNA expression decreased in 
the neocortex but was clear in the choroid 
plexus and other epithelial linings as well 
as in the peripheral ganglia.
4.1.5 Possible roles for Na+-K+-Cl- 
cotransporter isoform 1 and cation-Cl- 
cotransporter isoforms in the regulation 
of embryonic development
Neuronal precursors and maturing neurons 
in the embryonic VZ and CP layers 
express functional GABAA receptors 
before the formation of functional synaptic 
contacts (LoTurco et al., 1995;Owens et 
al., 1996;Owens and Kriegstein, 2002). 
These receptors mediate depolarizing 
GABA currents which are required for 
trophic GABA effects (LoTurco et al., 
1995;Owens et al., 1996;Owens and 
Kriegstein, 2002). The depolarizing 
GABA responses of VZ and CP evidently 
result from the Cl- intruding activity of 
NKCC1, which is highly expressed in the 
immature neurons of these layers (Sung 
et al., 2000;Yamada et al., 2004;Dzhala 
et al., 2005). This has been shown also 
in adult newborn neurons, in which 
NKCC1 maintains the depolarized EGABA-
A essential for correct synapse formation 
and dendritic development (Ge et al., 
2006). Knock-down of NKCC1 mRNA 
in newborn neurons results in marked 
defects in denritic arborization as the total 
dendritic length and branch number as 
well as the dendritic complexity of these 
neurons is significantly reduced (Ge et 
al., 2006). In addition, NKCC1 may have 
a role in the regulation of the cell cycle 
of neuronal precursors of the VZ layer. 
These cells undergo several cell cycles 
to generate postmitotic neurons, and 
an increase in cell size is an important 
variable in determining the timing of cell 
division (Gao and Raff, 1997). Thus it is 
plausible that by mediating the regulatory 
cell volume increase, NKCC1 might be 
involved in the control of the neuronal cell 
cycle. Indeed, experiments in cultured non-
neuronal cells have indicated a role for the 
NKCC-mediated cell volume regulation 
mechanism in cell proliferation (Panet 
and Atlan, 1991;Bussolati et al., 1996). 
However, possible defects in neurogenesis 
remain to be shown in NKCC1 KO mice.
The expression of NKCC1, KCC1, 
and KCC4 was strong in the embryonic 
choroid plexus. The epithelial cells of 
the choroid plexus secrete cerebrospinal 
fluid, by a process which involves the 
transport of Na+, Cl-, and HCO3
- from 
the blood to the ventricles of the brain 
(Brown et al., 2004). The transport of 
ions is unidirectional due to the polarity 
of the epithelium, i.e. the ion transport 
proteins in the blood-facing (basolateral) 
membrane are different to those in the 
ventricular (apical) membrane (Brown 
et al., 2004). In adult animals, NKCC1 
is confined to the apical membrane of 
choroid plexus epithelial cells (Plotkin et 
al., 1997a), but the role of the protein in 
the apical membrane is unclear. In addition 
to NKCC1, Na+-K+-ATPase is located at 
the apical membrane and serves as the 
dominant pathway for secretion of Na+ to 
CSF (Brown et al., 2004). NKCC1 may, 
however, also contribute to the secretion 
of Na+, and at the same time enrich the 
CSF with K+ to feed the Na+-K+-ATPase 
(Bairamian et al., 1991;Javaheri and 
Wagner, 1993;Keep et al., 1994). In the 
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adult nervous system, KCC4 protein is 
located at the apical membrane and KCC3 
is strongly expressed in the basolateral 
membrane of choroid plexus (Pearson et 
al., 2001;Karadsheh et al., 2004), whereas 
the exact localization of KCC1 protein 
is not known. In the embryonic brain, 
however, KCC3 is absent from the choroid 
plexus. Thus it may be plausible that in the 
embryonic brain, KCC1 substitutes for 
KCC3 as the basolateral KCC isoform, 
and KCC4 serves as the apical isoform. 
In this case, KCC1 may have a signifi cant 
role in the absorption of K+ from the CSF 
to the blood. The hypothesis is supported 
by the fact that no other transporters or 
channels capable of mediating K+ effl ux 
have been identified in the basolateral 
membrane (Brown et al., 2004). KCC4 
might be involved in Cl- secretion and at 
the same time contribute to the recycling 
of K+ similar to NKCC1.
The expression profiles of KCCs 
revealed a non-overlapping regional 
expression in the embryonic rodent 
brain; KCC2 was present in mature 
regions and KCC3 in newly differentiated 
regions, whereas KCC4 was abundant 
in undifferentiated proliferative zones. 
These KCC isoforms display different 
characteristics in their kinetics and 
activation (Mercado et al., 2000;Gamba, 
2005), making them suitable for different 
tasks. For example, among the KCC 
isoforms, KCC4 displays the most robust 
cell swelling-induced activity (Mercado 
et al., 2000), and KCC2 is unique in 
having constitutive Cl- extrusion activity. 
The neonatal expression of KCC2 in 
the spinal cord and brainstem is crucial 
for normal spinal cord reflexes and 
respiratory motoneuron function (Hubner 
et al., 2001b). KCC3 is mutated in a 
severe peripheral neuropathy associated 
with agenesis of the corpus callosum 
(Howard et al., 2002). As this structure 
forms during embryogenesis, the callosal 
agenesis indicates that KCC3 is at least 
indirectly involved in early axonal 
migration. The robust expression of KCC4 
in the proliferative zones of embryonic 
brain implies a role for the cotransporter 
in the cell volume regulation associated 
with the proliferative cell cycling during 
embryogenesis.
4.2 Generation of cation-Cl- 
cotransporter isoform 2-defi cient mice 
(II)
4.2.1 Construction of gene targeting 
vectors
The mouse is the leading vertebrate 
experimental model because its genome 
can be effi ciently and precisely engineered 
by various means. Targeted mutagenesis 
into ES cells is a generally used technique 
for the production of mutant mice to study 
a gene function in vivo (Nagy and Rossant, 
1996). In order to characterize the in vivo 
roles for KCC2, we generated transgenic 
mice with KCC2 null and hypomorphic 
alleles. For this purpose, we developed a 
novel in vitro DNA transposition-based 
system for the generation of mutant allele-
producing targeting vectors.
Transposons are mobile genetic 
elements that can relocate between 
genomic sites by a special form of DNA 
recombination called DNA transposition 
(Mizuuchi, 1997;Hayes, 2003). DNA 
transposition-based methods are utilized 
widely in molecular biology techniques, 
such as DNA sequencing, gene mapping, 
and insertional mutagenesis (Hayes, 2003). 
The main advantage of using transposons 
in genetic engineering is their ability 
to integrate efficiently and relatively 
randomly into target DNA. One of the 
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best-characterized DNA transposition 
systems is an in vitro system derived 
from Bacteriophage Mu transposition 
(Mizuuchi, 1983;Haapa et al., 1999b), 
which only requires three purified 
macromolecular components: transposon 
DNA, transposase protein MuA and target 
DNA.
In order to construct appropriate 
gene targeting vectors for KCC2 null, 
hypomorphic, and conditional alleles, 
we fi rst customized a 1418 bp mini-Mu 
transposon DNA called Neoflox-Mu. 
At its ends this transposon contained, as 
inverted repeats, 50 basepairs of R-end 
DNA (Savilahti et al., 1995). Between 
these recognition sites of the Mu 
transposon were: 1) a marker neomycin 
phosphotransferase (neo) resistance gene 
under the control of eukaryotic thymidine 
kinase promoter (ptk) and 2) the marker 
gene fl anking loxP sites. The loxP sites 
enable the excision of the DNA segment 
between pairs of these sites in cells 
expressing functional Cre recombinase 
(Sauer, 1998;Nagy, 2000). As target DNA, 
we used a 6688 bp genomic clone of the 
mouse Slc12a5 gene including exons 2-6 
(Haapa et al., 1999a).
The transposon Neoflox-Mu was 
introduced into the genomic Slc12a5 clone 
by in vitro DNA transposition (Haapa et 
al., 1999a). The suitable gene targeting 
vectors were then screened for by PCR 
analysis. For the null mutant allele, the 
PCR reaction was designed to identify 
sense orientated transposon integrations 
into exon 4. One of the integrants contained 
the transposon 14 bp downstream from the 
5’-end of exon 4, and was chosen as the 
vector for targeting the knock-out allele 
(Fig 3A).
The insertion of neo cassette into 
introns, as well as in 5’- or 3’-fl anking, 
or untranslated regions of the gene, 
can interfere with the expression of the 
targeted allele (Lewandoski, 2001). In 
some cases, it has been determined that 
intronic neo insertion creates hypomorphic 
alleles either through cryptic splicing 
signals in neo that lead to a frameshift, 
or by down-regulating gene expression 
through an unknown mechanism (Jacks 
et al., 1994;Meyers et al., 1998;Nagy 
et al., 1998). Thus, for the generation 
of the hypomorphic allele, we chose 
a construct that harbored an antisense 
orientated transposon in intron 3 (Fig. 3B). 
Intronically positioned neo may, however, 
lead to unexpected inhibitory effects on the 
expression of neighboring genes (Olson 
et al., 1996). This type of phenomenon 
seems to arise when the targeted gene is a 
part of a multigene group such as GABAA 
receptor β2-α6-α1-γ2 subunit gene cluster 
(Uusi-Oukari et al., 2000), Hox gene 
clusters (Rijli et al., 1994), or β-globin 
gene cluster (Fiering et al., 1993). The 
clustered organization of multigene groups 
implies that transcriptional elements might 
be shared by two or more genes, or that 
elements controlling one gene may be 
located within DNA sequences of another. 
The mechanisms for the neo-induced 
neighboring effect is not yet identified, 
but may include direct inhibition of 
neighboring genes, or indirect inhibition 
of local transcriptional elements shared by 
many genes (Uusi-Oukari et al., 2000).
The Slc12a5 gene locus is located on 
mouse chromosome 2H2-H3 (Sallinen 
et al., 2001). Genes in the immediate 
neighbourhood of this loci (spanning ~70 
kb up- or downstream) include Mmp9 
(encoding matrix metallopeptidase 9 
(MMP9)), Ncoa5 (encoding nuclear 
receptor coactivator (Ncoa)), LOC629777 
( encod ing  hypo the t i c a l  p ro t e in 
LOC629777)), Zpf335 (encoding zinc 
finger protein (Zfp335)), and Cd40 
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(encoding antigen CD40) (NCBI). This 
group of genes does not form a cluster 
of related genes, and it is not obvious 
that these genes would be sharing 
transcriptional elements. However, we 
cannot exclude the possibility that neo 
in Slc12a5 locus might interfere with the 
expression of above mentioned genes, 
or other genes at more distant locations. 
Thus the interpretation of the phenotypes 
from the KCC2-defi cient mice might be 
confounded by the disrupted expression of 
the genes located near the intended target. 
From the neighboring genes, MMP-9 
and CD40 are known to be expressed in 
the CNS. MMP-9 belongs to a family of 
proteolytic matrix metalloproteinases, 
which expression in the CNS is customarily 
thought to be associated with injury or 
pathology (Yong et al., 2001). Some 
MMP isoforms, such as MMP-9, may 
have a role in normal ontogeny, and this 
isoform has been shown to be necessary 
for oligodendrocyte process extension 
and myelination (Uhm et al., 1998;Oh 
et al., 1999;Larsen et al., 2006), and is 
possibly required for hippocampal late-
phase long-term potentiation and memory 
(Nagy et al., 2006). CD40 is a member 
of the tumor necrosis factor receptor 
family participating in the regulation of 
pro-infl ammatory and immune responses 
in the brain (Chen et al., 2006). These 
two gene products display distinguishly 
different functions compared to KCC2, 
and the phenotypes observed in KCC2-
deficient mice (III, IV) might not be 
readily explained by the neo-induced 
neighboring gene effect. The function of 
the other genes neighboring the Slc12a5 
locus is unknown.
The conditional allele-containing gene 
targeting construct was generated from the 
hypomorphic allele-containing clone by 
introducing an additional loxP site into a 
unique HpaI site residing in intron 1 of 
the Slc12a5 gene. We did not, however, 
proceed to generate the KCC2 conditional 
allele mouse line.
The selected constructs for null and 
hypomorphic alleles were targeted into the 
endogenous Slc12a5 locus by homologous 
Fig. 3. Targeting of Slc12a5. A) The 
targeting construct for the generation of the 
KCC2null allele. The construct contained a 
neo selection cassette inserted into exon 
4 of Slc12a5. Depicted also are the wild-
type locus Slc12a5, and the resultant null 
mutant allele. Neoflox-Mu transposons 
are shown as rectangles containing LoxP 
sites (black arrowheads) and transposon 
ends (white arrowheads). The intron-exon 
sequence and the relevant restriction sites 
(B, BamHI) and the primers for genotyping 
(P1-P4) are shown. B) The targeting 
construct for KCC2 hypomorphic allele 
that contains an inverted neocassette in 
intron 3 of a genomic Slc12a5 clone.
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recombination. For the null mutant 
allele, disruption of exon 4 with the neo 
cassette caused a protein truncation and 
complete loss of the protein, whereas 
the hypomorphic mutant allele with an 
inverted neo in intron 3 resulted in the 
anticipated down-regulation of KCC2 
expression. Mice homozygous for the 
hypomorphic allele (KCC2hy/hy) showed a 
60-70% reduction of normal KCC2 levels 
in the brain.
4.2.2 General characteristics of cation-
Cl- cotransporter isoform 2-defi cient mice 
(III)
Consistent with the work of Hubner and 
collaborators (Hubner et al., 2001b), 
our KCC2 knock-out mice died shortly 
after birth apparently due to defects in 
the respiratory system, whereas mice 
homozygous for the KCC2 hypomorphic 
allele (retaining 30-40% of normal 
KCC2 levels) were viable and showed 
no obvious phenotypes (I). To produce 
KCC2 hypomorphic mice with more 
informative phenotypes, we intercrossed 
heterozygous mice for the null and 
hypomorphic alleles, which resulted in 
heteroallelic KCC2hy/null mice retaining 15-
20% of normal KCC2 levels in the brain 
and spinal cord, as assessed by Western 
blotting. Immunohistochemical analysis 
with a KCC2-specific antibody showed 
that the reduction of KCC2 expression 
in KCC2hy/null mice was universal as the 
overall KCC2 distribution pattern was 
similar in mutant and wild-type mice. 
In addition, the mutant mice displayed 
no compensatory changes in other KCC 
family members or NKCC1 as detected by 
RT-PCR or Western blotting.
The KCC2hy/null mice displayed normal 
reproduction and life span, but had a 
reduced body weight (-20% in both sexes). 
The weight difference emerged two weeks 
after birth and persisted throughout the 
adult life of the animals. The mechanism 
behind the reduced weight remains 
unknown. Apart from the mild weight 
reduction, the mutant mice displayed no 
other obvious phenotypes, as the body 
position, spontaneous activity, respiration 
rate, palpebral closure, fur condition, 
gait, pelvic elevation, trunk curl, limb 
grasping, visual placing, and grip strength 
of the mutant mice was similar to wild-
type control mice. Standard histological 
analysis of the brain morphology 
with haematoxylin and eosin staining 
revealed no gross changes between 
the genotypes. Moreover, a descriptive 
light microscope analysis suggested 
that the density and morphology of cell 
bodies and the density of synapses in the 
hippocampus and cortex were normal in 
the KCC2hy/null mice. This was addressed 
by immunohistochemical analysis with 
antibodies against parvalbumin, calbindin, 
and synaptophysin.
4.3. Behavioral and in vivo 
pharmacological characterization of 
cation-Cl- cotransporter isoform 2 
mutant mice (III,IV)
The role for KCC2 in hyperpolarizing 
GABA inhibi t ion has been well 
characterized (Rivera et al., 1999;Hubner 
et al., 2001b;Woo et al., 2002;Zhu et al., 
2005), but little is known concerning the 
role of KCC2 at the systems level. In 
addition, no experimental evidence exists 
regarding the role of KCC2 in the tonic 
form of GABA inhibition. To address 
these questions, we decided to study the 
signifi cance of reduced KCC2 levels on 
adult mouse behavior, and test the relative 
importance of KCC2 in the tonic versus 
phasic GABAergic inhibition in the adult 
CNS, and the related behavior in vivo.
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Consistent with the role of KCC2 
in establishing hyperpolarizing GABA 
responses (Rivera et al., 1999;Hubner 
et al., 2001b;Woo et al., 2002;Zhu et al., 
2005), the KCC2hy/null mice displayed 
significantly depolarized EGABA-A values 
in hippocampal CA1 pyramidal cells 
compared to wild-type control mice 
(EGABA-A, WT: -69 ± 4 mV, n=6, hy/
null: -48±5 mV, n=5) (R Riekki et al., 
unpublished results). Consequently, 
the normally hyperpolarizing GABA 
responses in hippocampal pyramidal cells 
were abolished in KCC2-defi cient mice.
4.3.1 Potential limitations to the 
genetically modifi ed mouse models in the 
investigation of the γ-aminobutyric acid 
type A receptor neurotransmission system
Experimental data from genetically 
modi f ied  KO or  KI  (knock- in) 
mice associated with the GABAA 
neurotransmission has proven this 
system to be critically involved in the 
control of a variety of physiological 
behaviors, including motor coordination, 
spontaneous locomotion, learning and 
memory, nociception, anxiety, panic, and 
epileptogenesis (table 6). A limitation to 
the GABA receptor subunit KO studies 
is the possible compensation by the 
remaining GABAA family members or 
by other molecules in unrelated systems 
(Brickley et al., 2001;Rudolph and Mohler, 
2004). In addition, targeted inactivation 
of the GABAA receptor subunits may 
result in a substantial loss of total GABAA 
receptors in brain (Sur et al., 2001;Kralic 
et al., 2002a). As discussed below, these 
phenomena may mask the true function 
of the targeted gene and thus make 
interpretation of the results diffi cult.
GABAA receptor α1 subunit is the 
most abundant α subunit variant in the 
brain and is highly expressed throughout 
most brain regions (Pirker et al., 2000). 
Mice that lack the α1 subunit displayed 
more than 50% loss of total GABAA 
receptors, but were viable, fertile, and 
showed no spontaneous seizures (Sur 
et al., 2001;Kralic et al., 2002a). These 
mice exhibited compensatory increases in 
the expression of α2 and α3 subunits and 
down-regulation of β2/3 and γ2 subunits 
in the forebrain (Sur et al., 2001;Kralic et 
al., 2002a).
GABAA receptor α6 subunit is 
exclusively expressed in cerebellar and 
cochlear nucleus granule cells (Laurie 
et al., 1992a;Varecka et al., 1994). 
Mice that lack the α6 subunit showed a 
compensatory up-regulation of TASK-1 
potassium channels and a ~25% loss of δ 
subunits in cerebellar granule cells (Jones 
et al., 1997;Brickley et al., 2001). The 
continuously active TASK-1 channels fully 
compensated the tonic GABA currents 
abolished by the deletion of α6 subunit-
containing GABAA receptors, and thus 
maintained the normal cerebellar granule 
cell excitability (Brickley et al., 2001).
GABAA receptor β2 subunit is the 
most abundant of the β subunits and is 
expressed in virtually all brain regions 
(Pirker et al., 2000). Consistent with its 
widespread distribution, deletion of the β2 
subunit results in more than 50% reduction 
of the total number of GABAA receptors 
(Sur et al., 2001). The β2 KO mice 
displayed, however, surprisingly normal 
phenotype being viable, fertile, and devoid 
of spontaneous seizures. The β2 subunit 
KO mice showed reduced expression 
levels (~50%) of all six α subunits (Sur et 
al., 2001).
GABAA receptor β3 subunit is 
strongly expressed in the cerebral cortex, 
hippocampus, hypothalamus, cranial nerve 
ganglia, and spinal cord in adults, and is 
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even more widespread and abundant in the 
prenatal brain (Wisden et al., 1992;Laurie 
et al., 1992b). Deletion of the β3 subunit 
produced several behavioral defi cits and 
epilepsy, and resulted in reduction of the 
total number of brain GABAA receptors 
containing α2 or α3 subunits (Homanics et 
al., 1997;Ramadan et al., 2003).
The GABAA receptor γ2 subunit 
is expressed throughout the brain, is 
incorporated in most postsynaptic 
GABAA receptor subtypes, and mediates 
postsynaptic clustering of GABAA 
receptors and gephyrin (Essrich et al., 
1998;Pirker et al., 2000;Schweizer et 
al., 2003). This GABAA receptor subunit 
has an obligatory role in benzodiazepine 
responsiveness (Pritchett et al., 1989). 
Consistent with this, γ2 subunit KO 
mice displayed 94% reduction of the 
benzodiazepine binding site, but showed 
an unchanged number of GABAA receptors 
(Gunther et al., 1995). This may be due to 
receptor subtypes composed only of α and 
β subunits, indicating that γ2 subunit is 
dispensable for the assembly of functional 
GABAA receptors (Gunther et al., 1995).
GABAA receptor δ subunit is primarily 
expressed in the extrasynaptic membranes 
and shows abundant expression in the 
cerebellar granule cells (Nusser et al., 
1998), and in forebrain regions such as 
thalamic relay nuclei, caudate-putamen, 
molecular layer of dentate gyrus and 
outer layer of cerebral cortex (Peng et al., 
2002). Mice that lacked δ subunit showed 
an extensive up-regulation of γ2 subunit 
in the cerebellum and forebrain, whereas 
the expression of α4 was reduced in the 
forebrain (Tretter et al., 2001;Peng et al., 
2002;Korpi et al., 2002b). In δ subunit 
KO mice, γ2 seemed to replace δ subunit 
by coassembling with α6 subunit in the 
cerebellum and α4 subunit in the forebrain 
(Tretter et al., 2001;Peng et al., 2002;Korpi 
et al., 2002b), implying a possible subunit 
competition during the assembly of 
GABAA receptors. The δ subunit KO 
mice were viable but exhibited attenuated 
sensitivity to neuroactive steroids (Mihalek 
et al., 1999).
Such adaptive compensatory changes 
are not, however, apparent in GABAA 
receptor α3 and α5 subunit, GABA 
transporter-1 (GAT1) and GAD65 KO 
mice (Kash et al., 1999;Collinson et 
al., 2002;Jensen et al., 2003;Yee et 
al., 2005). GABAA receptor α3 and α5 
subunits are of minor abundance in the 
brain. GABAA receptors that contain α3 
subunit are the main subtypes expressed in 
monoaminergic and basal cholinergic cells 
(Gao et al., 1993). In addition, this receptor 
subtype is expressed in the olfactory bulb, 
cerebral cortex, reticular thalamic nucleus, 
superior colliculus, amygdala, and cranial 
nerve nuclei. The primarily extrasynaptic 
α5 subunit-containing GABAA receptors 
are expressed to a signifi cant extent only 
in the hippocampus, but display also low 
expression in the olfactory bulb, cerebral 
cortex, and the hypothalamus (Pirker et 
al., 2000;Brunig et al., 2002). The α3 and 
α5 KO mice showed no alterations in the 
expression levels of other GABAA receptor 
subunit family members (Collinson et 
al., 2002;Yee et al., 2005). In addition, 
the GAD65 and GAT1 KO mice showed 
largely unaffected GABAA receptor 
expression (Kash et al., 1999;Jensen et al., 
2003). Out of four identifi ed GAT subtypes 
(GAT1-4), GAT1 is the major subtype and 
displays a particularly strong expression 
in hippocampus, neocortex, cerebellum, 
and retina (Guastella et al., 1990). GAD65 
is expressed in all GABAergic neurons 
(Erlander et al., 1991).
As mentioned earlier, the analysis of 
possible adaptive compensatory changes 
in the KCC2hy/null mice was restricted to 
the remaining KCC family members and 
NKCC1. Thus we do not know whether the 
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knock-down mutation of KCC2 induces 
compensatory changes in the organization 
and in the functional properties of GABAA 
receptors, or in other proteins associated 
with the GABAergic neurotransmission 
system. In addition, as discussed before, 
we cannot exclude the possibility that neo 
cassette might have induced inhibitory 
effects on the expression of the Slc12a5 
neighboring genes, or genes at more 
distant locations. For these reasons, we 
cannot be sure whether the phenotypes we 
observed in the KCC2hy/null mice are due to 
the reduced KCC2 expression in the adult 
animal, or whether the phenotypes results 
from adaptive compensations in the brain 
during development or the potential gene 
regulatory elements expressed in neo 
cassette.
The above mentioned problems have 
been tried to overcome by a variety of 
GABAA receptor KI mice that introduce 
more subtle point mutations to the mouse 
genome (Rudolph and Mohler, 2004). 
The idea is that the point mutation would 
specifi cally prevent the modulation of the 
respective receptor by a defi ned drug, but 
would leave the physiological function 
of the targeted molecule intact (Rudolph 
and Mohler, 2004). Some of the GABAA 
receptor subunit KI mice are presented 
in table 6 and are discussed more closely 
later.
Table 6 presents some of the 
behavioral phenotypes of genetically 
modifi ed mice associated with the GABAA 
neurotransmission system. The behaviors 
collected in the table are those that we 
observed to be altered in the KCC2hy/null 
mice. For the above mentioned reasons, 
the interpretation of the phenotypes for 
most of these mouse models may be 
difficult. In addition, differences in the 
testing conditions and in the background 
of the animals may cause confounding 
results that are not necessarily refl ecting 
the true function of the targeted protein. 
The behavioral phenotypes of KCC2-
defi cient mice and the possible relations 
of these phenotypes to the GABAergic 
neurotransmission system are discussed in 
the remaining chapters 4.3.2-4.3.11.
4.3.2 Cation-Cl- cotransporter isoform 
2 mutant mice display normal motor 
coordination and spontaneous locomotor 
activity (III)
The major brain regions for control of 
movement in vertebrates include spinal 
cord, brain stem, hypothalamus, basal 
ganglia, cerebral cortex, and cerebellum 
(Grillner, 2003). GABAA receptors are 
the main inhibitory receptors for fast 
inhibitory neurotransmission in all of these 
regions, except for the spinal cord where 
GABAA and glycine receptors are the main 
receptors for fast inhibitory tone (Wisden 
et al., 1992;Laurie et al., 1992a;Laube et 
al., 2002). Mice with targeted deletions 
of GABAA receptor subunit α1 and GAT1 
display readily observable tremor and 
consequently impaired performance in 
the rotarod (Chiu et al., 2005;Kralic et 
al., 2005) (table 6). The tremor observed 
in the GABAA receptor subunit α1 KO 
mice resembles a human essential tremor 
disorder with an unknown etiology (Chen 
and Swope, 2003;Kralic et al., 2005). 
Similarly, a gain-of-function GABAA 
receptor α1 (S270H) mutated mice, which 
display increased sensitivity to GABA 
and prolonged mIPSCs in hippocampal 
neurons, show intention tremor and 
impaired rotarod performance. In addition, 
mice devoid of β3 subunit have diffi culties 
in swimming, walking on grids, and fall of 
platforms and rotarods (Homanics et al., 
1997). Both GABAA receptor subunits α1 
and β3, as well as GAT1, are expressed 
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highly throughout the brain including the 
motor pathways in brainstem, cerebellum, 
cerebral cortex, and basal ganglia (Wisden 
et al., 1992;Laurie et al., 1992a;Yasumi et 
al., 1997;Pirker et al., 2000). As deletion 
of GAT1 results in elevation of GABA 
levels (Jensen et al., 2003), these results 
suggest that tremor and the subsequent 
impairment in motor coordination can 
arise from either too little or too much 
GABAergic neurotransmission throughout 
the brain.
KCC2-defi cient mice did not display 
tremor. We tested the sensorimotor control 
and coordination abilities of the mice 
by normal and accelerating rotarods, in 
which the performance depends primarily 
on neuronal circuits in the cerebellum, 
spinal cord, and brain stem (Grillner, 
2003;Schieber and Baker, 2003). In both 
rotarod setups, the KCC2hy/null displayed 
normal performance. The results imply 
that although KCC2 is highly expressed 
in CNS neurons required for motor 
coordination, including the granule cells 
and Purkinje neurons of the cerebellum 
(Payne et al., 1996), inhibitory synapses 
throughout the spinal cord (Hubner et 
al., 2001b;Coull et al., 2003), and brain 
stem nuclei that control posture and refl ex 
behaviors (e.g vestibular nucleus) (Kanaka 
et al., 2001), the proper functioning of 
these systems at the behavioral level was 
not critically altered by 80% reduction of 
KCC2 levels.
KCC2-defi cient mice were tested for 
spontaneous locomotor activity in novel 
open field environment. Dopaminergic 
neurotransmission has been shown to be 
critical in the regulation of motor activity, 
emotion, motivation, and cognition 
(Holmes et al., 2004), and alterations to the 
dopaminergic system lead to changes in 
the rodent spontaneous locomotor activity 
(Spielewoy et al., 2000;Holmes et al., 
2004). Dopaminergic pathways are known 
to be under the control of GABAergic 
inhibition, and mice with targeted 
mutations to GABAA receptor subunits 
α3, α5, β2, and β3 show hyperlocomotor 
activity (Homanics et al., 1997;DeLorey 
et al., 1998;Sur et al., 2001;Crestani et al., 
2002;Blednov et al., 2003;Hauser et al., 
2005;Yee et al., 2005). The mechanism 
for the enhanced locomotion in these 
mice is unclear, but the phenomenon 
is not associated with reduced anxiety 
levels (Crestani et al., 2002;Yee et al., 
2005). In addition, β3 KO mice display 
circling behavior, which is known to be 
indicative of defi cits in the dopaminergic 
neurons of the basal ganglia (Kaakkola 
and Teravainen, 1990). These observations 
imply that impaired GABAergic inhibitory 
control of the dopaminergic neurons 
might be one of the factors underlying the 
enhancement of locomotor activity.
We tested the spontaneous locomotor 
activity in KCC2 mutant mice in the open 
fi eld and Y-maze. In both of these tests, 
the KCC2hy/null mice displayed apparently 
normal spontaneous locomotor activity. 
KCC2 is not expressed in the nigrostriatal 
dopaminergic neurons (Gulacsi et al., 
2003), and thus it might be possible that 
KCC2 is not directly involved in the 
GABAergic inhibitory regulation of brain 
dopaminergic systems. Whether KCC2 is 
expressed in the three other anatomically 
distinct (mesolimbic, mesocortical, 
and tuberoinfundibular) dopaminergic 
pathways is not known. Dopaminergic 
neurons from the nigrostriatal and 
mesolimbic pathways express at least 
GABAA α2, α3, α4, β1, β3, and γ2 subunits 
(Okada et al., 2004).
Results and Discussion
39
4.3.3 The sedating/motor-impairing 
effect of diazepam, but not of gaboxadol, 
is reduced in cation-Cl- cotransporter 
isoform 2-defi cient mice (IV)
Because tonic GABA inhibition is mainly 
mediated via a shunting inhibition, which 
is independent of the inwardly directed 
Cl- gradient (Staley and Mody, 1992), 
we hypothesized that the tonic GABA 
inhibition would remain effective in 
KCC2 mutant mice. To investigate the 
requirements for KCC2 in tonic versus 
phasic GABA neurotransmission in the 
adult CNS, we selectively enhanced 
the activity of synaptic or extrasynaptic 
GABAA receptors on KCC2
hy/null mice by 
allosteric GABAA receptor modulators.
A classical benzodiazepine, diazepam, 
interacts with and enhances the activation 
of GABAA receptors that contain α1, α2, 
α3, or α5 subunits, but is unable to bind 
to GABAA receptors that contain mainly 
extrasynaptic α4 and α6 subunits (Rudolph 
and Mohler, 2004). The diazepam 
binding property of the α1, α2, α3, or 
α5 subunits is enabled by a conserved 
histidine residue (H101, rat α1 subunit 
numbering), whereas α4 and α6 subunits 
that contain a conserved arginine residue 
are unable to bind diazepam (Wieland 
et al., 1992;Benson et al., 1998;Rudolph 
and Mohler, 2004). The primarily 
extrasynaptically located δ subunit is 
found mostly to be associated with α4 and 
α6 subunits (Wisden et al., 1992;Jones et 
al., 1997), and there are several reports 
stating that the δ subunit containing 
GABAA receptors are distinguished by 
their insensitivity to benzodiazepines 
(Saxena and Macdonald, 1996;Brown 
et al., 2002). However, although native 
α4 and α6 subunits do not recognize the 
classical benzodiazepines (e.g. diazepam), 
there are certain benzodiazepine site 
ligands (e.g. fl umazenil and Ro15-4513) 
that are able to bind to these diazepam-
insensitive receptor subtypes (Wieland 
et al., 1992;Derry et al., 2004;Hanchar 
et al., 2006;Lindquist and Birnir, 2006), 
and may thus affect tonic GABAergic 
conductances mediated by the δ subunit-
containing GABAA receptors. In addition, 
rats homozygous for a naturally occurring 
point-mutation (R100Q) in the α6 subunit 
display diazepam and flunitrazepam 
sensitive α6/δ subunit-containing GABAA 
receptors (Santhakumar et al., 2006).
In the granule cells of the cerebellum 
and dentate gyrus, neocortex, and thalamic 
relay nuclei tonic GABAergic inhibition 
is, however, mediated by diazepam-
insensitive GABAA receptors that contain 
α6 or α4 subunits together with the δ 
subunit (Brickley et al., 1996;Nusser and 
Mody, 2002;Stell et al., 2003;Belelli et al., 
2005;Drasbek and Jensen, 2005;Cope et 
al., 2005;Mtchedlishvili and Kapur, 2006). 
In contrast, in the hippocampal CA1 
area, tonic inhibition is mediated by the 
diazepam-sensitive γ2 subunit-containing 
GABAA receptors in interneurons and, to a 
lesser extent, in pyramidal cells (Semyanov 
et al., 2003). This may, however, only 
occur due to experimental conditions that 
increase ambient GABA concentrations, 
and at low physiological ambient GABA 
concentrations the δ subunit-containing 
GABAA receptors predominate in 
mediating the tonic currents in the CA1 
area (Scimemi et al., 2005).
Mice with a point mutation in the 
GABAA receptor subunit α1 are insensitive 
to low-dose diazepam-induced sedation 
and motor impairment (Rudolph et al., 
1999;McKernan et al., 2000;Crestani et 
al., 2000), implying that the majority of 
diazepam-induced sedation is mediated 
through the activation of the α1 subunit-
containing GABAA receptors, which are 
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highly expressed in postsynaptic densities 
(Somogyi et al., 1996;Farrant and Nusser, 
2005). The brain regions that mediate 
the sedative effects of diazepam are not, 
however, known.
In order to specifi cally examine the 
role of KCC2 in the phasic (synaptic) 
form of GABAergic inhibition, we tested 
the locomotor-impairing/sedative effects 
of diazepam in the KCC2hy/null mice in the 
open fi eld. This test was chosen because 
the basal drug-free response of KCC2hy/null 
mice to novel open fi eld environment did 
not differ from their wild-type littermates 
(III). Diazepam (2 mg/kg) significantly 
depressed the spontaneous motor activity 
(distance travelled) in wild-type mice, but 
resulted in only a slight decrease of the 
spontaneous motor activity in the KCC2hy/
null mice. This resistance to diazepam-
induced sedation was consistent with 
the reported role of KCC2 in synaptic 
GABAergic inhibition (Rivera et al., 
1999;Hubner et al., 2001b;Woo et al., 
2002;Zhu et al., 2005). In contrast to 
diazepam, gaboxadol (10 mg/kg) impaired 
the locomotor activity in the open field 
test similarly between the genotypes. 
As the diazepam-insensitive, primarily 
extrasynaptic δ subunit-containing GABAA 
receptors are the main target for gaboxadol 
(Brown et al., 2002;Krogsgaard-Larsen 
et al., 2004;Maguire et al., 2005;Belelli 
et al., 2005;Cope et al., 2005;Chandra et 
al., 2006), the result suggested that tonic 
GABA inhibition might be relatively intact 
in the KCC2-defi cient mice. 
The difference in the behavioral 
response of KCC2hy/null mice to drugs 
that preferentially enhanced either phasic 
or tonic GABA inhibition was clear. 
However, because of the lack of in vitro 
pharmacological analysis of the KCC2-
deficient mice, we do not know the 
exact cellular effects of diazepam and 
gaboxadol, and various other drugs used 
throughout this thesis. These experiments 
would provide strong and solid supporting 
evidence to the in vivo pharmacological 
data presented in this thesis, and will 
hopefully be a subject of future studies.
4.3.4 Cation-Cl- cotransporter isoform 
2 mutant mice display normal motor 
impairment responses to alcohol but not 
to diazepam (IV)
Alcohol is known to directly modulate 
the activity of a variety of receptors 
and ion channels, including ionotropic 
glutamate receptors, potassium channels, 
adenosine receptors, GABAA receptors, 
5-HT3 receptors, and neuronal nicotinic 
acetylcholine receptors (Wallner et al., 
2006).
A l c o h o l  i n t o x i c a t i o n  a l t e r s 
coordination and motor skills. Although 
the precise mechanism of action of alcohol 
in motor impairment is unknown, alcohol 
may, in part, act by interfering with 
normal cerebellar functioning (Carta et 
al., 2004;Hanchar et al., 2005;Valenzuela 
et al., 2005). Glutamatergic cerebellar 
granule cells receive sensory information 
from mossy fibers and relay it to 
Purkinje neurons via the parallel fibers 
(Houk and Mugnaini, 2003). Mossy 
fi ber input is fi ltered at granule cells by 
inhibitory neurotransmission provided 
by Golgi interneurons, which profoundly 
modulates cerebellar information storage 
capacity (Semyanov et al., 2004). Golgi 
interneurons provide tonic and phasic 
GABAergic input to granule cells, which 
express a limited set of GABAA receptor 
α1, α6, β2/3, γ2, and δ subunits, of which 
the δ subunits are found exclusively in 
the extrasynaptic membranes (Nusser et 
al., 1998). The α6 subunit is reported to 
be expressed exclusively in the cerebellar 
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granule cells and cochlear nucleus (Laurie 
et al., 1992a;Varecka et al., 1994). In 
cerebellar granule cells, the δ subunits 
subunits partner principally with α6 
subunits (Jechlinger et al., 1998;Poltl 
et al., 2003), and these GABAA receptor 
subtypes are necessary for tonic inhibition 
(Brickley et al., 2001).
There are controversial results with 
respect to the significance of ethanol 
on tonic GABA currents generated by 
extrasynaptic GABAA receptors. When 
recombinantly expressed in Xenopus 
oocytes, the α4β2/3δ and α6β2/3δ 
combinations of GABAA receptors have 
been reported to show high sensitivity to 
low ethanol concentrations (Sundstrom-
Poromaa et al., 2002;Wallner et al., 
2003;Hanchar et al., 2005), suggesting that 
low ethanol selectively potentiates GABA 
currents mediated by δ subunit-containing 
GABAA receptors. This claim was not, 
however,confi rmed by a recent consortium 
study from four different independent 
laboratories using identical experimental 
conditions (Borghese et al., 2006), or by a 
recent report using mammalian cell lines 
that expressed GABAA receptor subtypes 
α4β2δ, α6β2δ, and α6β3δ (Yamashita et al., 
2006). In addition, in cultured cerebellar 
granule cells, the effect of ethanol on 
α6β2δ GABAA receptors ranged from a 
slight potentiation to a slight inhibition of 
GABA currents, suggesting that changes 
in the intracellular milieu might play a 
role in the ethanols effects on δ-containing 
GABAA receptors (Yamashita et al., 
2006).
Conflicting results have also been 
obtained from studies using rats with a 
point-mutation (R100Q) in the GABAA 
receptor α6 subunit (Hanchar et al., 
2005;Valenzuela et al., 2005). This 
polymorphism occurs naturally in outbred 
strains of Sprague-Dawley rats and was 
reported to render rats homozygous for 
the mutation more sensitive to low (1.25 
g/kg) ethanol-induced motor-impairment 
(Hanchar et al., 2005). The same report also 
demonstrated low ethanol enhancement 
of tonic GABA currents in cerebellar 
granule cells in slice preparations, and 
that this enhancement was potentiated in 
homozygous α6(R100Q) rats (Hanchar et 
al., 2005). This tonic current enhancing 
effect of α6(R100Q) polymorphism was 
not confirmed by another report using 
inbred alcohol-nontolerant and alcohol-
tolerant rats, which were homozygous for 
the α6(R100Q) and α6(R100R) genotypes, 
respectively (Valenzuela et al., 2005). This 
report, however, confi rmed the effect of 
low ethanol in enhancing tonic GABA 
currents in cerebellar granule cells in slice 
preparations (Valenzuela et al., 2005). 
Finally, a recent report demonstrated that 
the low ethanol-induced increase in tonic 
GABA currents in cerebellar granule cells 
might be due to increased presynaptic 
GABA release, rather than a postsynaptic 
effect of ethanol (Carta et al., 2004).
Despite the controversial reports 
regarding the postsynaptic GABAA targets 
for ethanol, the mechanisms by which 
ethanol enhances tonic GABA currents, 
or whether ethanol has any role in 
modulating tonic GABAergic currents (see 
discussion above), the fact remains that 
three independent groups have shown that 
low ethanol induces an enhancement of 
tonic GABA currents in vitro in cerebellar 
granule cells in slice preparations (Carta et 
al., 2004;Hanchar et al., 2005;Valenzuela 
et al., 2005).
We tested the motor-impairing effect 
of low (1.25 g/kg, i:p.) dose of ethanol on 
KCC2hy/null mice on an accelerating rotarod. 
The mice were tested before (pretrial) and 
after the ethanol injection. Importantly, 
motor abilities were similar between the 
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genotypes in the drug-free pretrial test. 
Ethanol injection significantly impaired 
motor coordination in both genotypes, and 
the alcohol-induced motor impairment 
revealed no differences between the 
genotypes. As KCC2 is highly expressed 
in the cerebellar granule cells (Payne et 
al., 1996;Rivera et al., 1999;Kanaka et 
al., 2001;Mikawa et al., 2002), this result 
is consistent with a recent report showing 
that blockade of almost all (~80%) of 
KCl cotransport in cerebellar granule 
cells in slices is not affecting tonic GABA 
currents (Hamann et al., 2002). As the 
cerebellar information processing is 
profoundly modulated by these shunting 
GABA currents in the cerebellar granule 
cells (Mitchell and Silver, 2003), the 
results presented here imply the integrity 
of tonic GABAergic inhibition in the 
cerebellum of KCC2-defi cient mice. We 
still, however, lack the key experiment 
of directly measuring the effect of low 
ethanol on cerebellar granule cell tonic 
GABA currents in the KCC2-deficient 
mice.
To further compare the effect of phasic 
vs tonic enhancement of GABAergic 
inhibition in the KCC2hy/null mice in the 
same behavioral task, we repeated the 
accelerating rotarod test by replacing the 
ethanol by diazepam. Again, the pretrial 
test showed no differences in the motor 
abilities between the genotypes. Diazepam 
(3 mg/kg, i.p.) signifi cantly impaired the 
motor abilities in both genotypes, but the 
diazepam-induced motor impairment/
sedation was considerably stronger in the 
wild-type mice. This was consistent with 
the open fi eld results, and suggests that the 
phasic GABAergic inhibition mediated 
by the α1 subunit-containing GABAA.
receptors is impaired in the KCC2hy/
null mice. The difference between the 
genotypes was smaller using higher dose of 
diazepam (10 mg/kg, i.p.), that cause more 
severe impairment of rotarod performance. 
This is consistent with previous results that 
the sedative and myorelaxant actions of 
higher dose of diazepam are mediated also 
via other GABAA receptors than synaptic 
α1 subunit-containing GABAA receptors 
(Rudolph et al., 1999;McKernan et al., 
2000;Crestani et al., 2000).
4.3.5 Neurosteroid-induced hypnosis 
and anticonvulsant potency of propofol 
are normal in cation-Cl- cotransporter 
isoform 2 mutant mice (III, IV)
Extrasynaptic GABAA receptors that 
contain the δ subunit are highly sensitive 
to neuroactive steroids in vitro (Wohlfarth 
et al., 2002;Stell et al., 2003). The in vivo 
effect of neurosteroids on these receptors 
has been demonstrated in δ subunit KO 
mice, which show reduced duration 
of loss of righting reflex (LORR) in 
response to neurosteroids pregnanolone 
and alphaxalone (Mihalek et al., 1999). In 
addition, in vitro studies demonstrate that 
pregnanolone exhibits a clear separation 
of efficacy between γ2 and δ subunit-
containing GABAA receptors, showing 
a particularly high efficacy for α4β3γ 
GABAA receptor subtype (Pillai et al., 
2004). The neuroanatomical targets for the 
hypnotic action of neurosteroids are not 
known, but may include thalamocortical 
relay neurons and granule cells of the 
dentate gyrus (Stell et al., 2003;Belelli et 
al., 2005). As thalamocortical neurons are 
a known target for general anaesthetics 
(Rudolph and Antkowiak, 2004), and 
the thalamocortical neurons of the 
ventrobasalis complex display δ subunit 
containing GABAA receptor-mediated 
tonic currents (Belelli et al., 2005), it may 
be that the hypnotic action of neurosteroids 
is mediated at least partly by this area. In 
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addition to this region, neurosteroids show 
selective enhancement of tonic δ subunit-
mediated GABA currents in dentate gyrus 
granule cells (Stell et al., 2003). In both of 
these cell types, the relay neurons of the 
thalamus and granule cells of the dentate 
gyrus, KCC2 shows a high expression 
(Gulyas et al., 2001;Bartho et al., 2004).
In animal studies, LORR is used as 
a marker for the hypnotic state, which 
is commonly defined as a drug-induced 
impairment of the cognitive functions 
required for responding to environmental 
stimuli (Rudolph and Antkowiak, 2004). 
Thus, in order to test the neurosteroid 
effect in KCC2 mutant mice, we conducted 
a pregnanolone induced (8 mg/kg, i.v) 
LORR in these mice. The results revealed 
no difference in the duration of LORR 
between the KCC2hy/null mice and wild-
type littermates.
P ropofo l  i s  a  w ide ly  u sed 
anaesthetic, and has been shown to 
possess anticonvulsant properties 
against seizures induced by electroshock 
and chemoconvulsants (Lowson et 
al., 1990;Ahmad and Pleuvry, 1995). 
Propofol acts on GABAA receptors that 
contain any of the β subunits β1, β2, and 
β3 (Smith et al., 2004), but also interacts 
with targets distinct form the GABAA 
receptor, including sodium channels 
(Ratnakumari and Hemmings, Jr., 1997), 
potassium channels (Magnelli et al., 
1992), cation channels (Ih) (Higuchi 
et al., 2003), calcium channels (Inoue 
et al., 1999), and glutamate channels 
(Orser et al., 1995). In hippocampal 
CA1 interneurons and pyramidal cells, 
electrophysiological studies have shown 
that propofol enhances GABAA receptor-
mediated responses predominantly 
through the shunting effect (Bai et al., 
1999;Bieda and MacIver, 2004). Tonic 
inhibition in these cells has been reported 
to be mediated by α5 and γ subunit-
containing GABAA receptors (Bai et al., 
2001;Semyanov et al., 2003;Caraiscos et 
al., 2004), but this receptor subtype may 
only be recruited when ambient GABA 
concentration increases, and at low 
ambient GABA concentrations, activation 
of δ subunit-containing GABAA receptors 
predominates (Scimemi et al., 2005). 
Propofol substantially enhances both γ and 
δ subunit-containing GABAA receptors in 
vitro, but is more potent on the receptors 
that contain the γ subunit (Feng and 
Macdonald, 2004). This implies that in 
hippocampal pyramidal cells, propofol 
enhances both phasic mIPSCs and tonic 
GABA currents, but may be more potent 
in enhancing tonic GABA currents when 
ambient GABA is elevated and the 
tonic GABA current is mediated by the 
activation of α5 and γ containing GABAA 
receptors.
We tested the anticonvulsant potency 
of this drug in the KCC2hy/null mice in an 
acute pentylenetetrazole (PTZ)-seizure 
model. Interestingly, the protective effect 
of propofol against seizures revealed no 
difference between the KCC2hy/null and 
control littermates. As propofol has a 
potent role in enhancing tonic GABA 
currents, we interpret this result to be 
consistent with the gaboxadol-induced 
sedation, the alcohol-induced motor 
impairment test and neurosteroid-induced 
LORR. Taken together, the results from 
these four experiments suggest that a 
profound (80-85%) reduction in KCC2 
levels does not affect the efficiency of 
tonic GABAergic signalling in KCC2hyä/null 
mice as assessed at the behavioral level. 
Further experiments are, however, needed 
to specifi cally measure the effect of these 
drugs at the cellular level.
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4.3.6 Electrophysiological measurement 
of tonic GABA currents in cation-Cl- 
cotransporter isoform 2-defi cient mice 
(IV)
Electrophysiological recordings were 
conducted to measure the tonic GABA 
currents at the cellular level in the KCC2-
deficient mice. When tonic GABAergic 
current was measured in hippocampal 
CA3 interneurons by conventional whole-
cell-clamp technique, no change in 
holding current was observed between the 
genotypes. This implies that tonic GABAA 
conductance, receptor expression, and 
extracellular GABA levels were unaltered 
in the KCC2-deficient mice. However, 
without a direct measuring of the effi cacy 
of the GABAA receptors that mediate the 
tonic currents or without a quantitative 
immuhistochemical analysis, we cannot 
completely exclude the possibility of 
adaptive plasticity (for example, KCC2hy/
null mice might display less GABAA 
receptors with higher efficacy and vice 
versa). When tonic current was measured 
using the gramicidin-perforated patch-
clamp configuration that maintains 
internal Cl- homeostasis, tonic current 
density (change in holding current per 
cell capacitance) was higher in the KCC2-
defi cient neurons when the cells were held 
at -80 mV. This indicates a more positive 
EGABA of the tonic current in these animals 
that is consistent with the positive shift 
in EGABA in synaptically induced GABAA 
receptor-mediated responses. This does 
not, however, necessarily compromise the 
effi ciency of tonic (shunting) inhibition in 
KCC2-defi cient mice as discussed below.
Shunting inhibition is a nonlinear 
phenomenon that behaves in an on-off 
like manner (Koch et al., 1983) and is 
efficient even if GABA is depolarizing 
(Staley and Mody, 1992). The key element 
in the shunting inhibition is the increase 
in membrane conductance, which limits 
depolarization above EGABA and therefore 
inhibits the membrane potential from 
reaching an action potential threshold, 
provided that the EGABA is below this 
value (Owens and Kriegstein, 2002). 
Thus the more positive EGABA of the tonic 
current observed in KCC2hy7null mice 
may not manifest at the behavioral level, 
because EGABA still remains hyperpolarized 
relative to action potential threshold, 
and the tonic current can still effectively 
diminish excitatory inputs. This does 
not, however, exclude the possibility that 
under certain conditions (such as during 
prolonged hyperexcitability) that lead 
to accumulation of intracellular chloride 
levels, the altered tonic current (due to 
reduced chloride extrusion capacity) in 
KCC2hy/null mice could manifest at the 
behavioral level, such as increased seizure 
susceptibility 
4.3.7 Cation-Cl- cotransporter isoform 2-
defi ciency results in anxiety-like behavior 
(III)
A diversity of neurotransmitters (e.g. 
GABA, glutamate, serotonin, and 
dopamine)  and neuromodula tors 
(e.g. cannabinoids, hormones, and 
neurotrophins) are involved in the 
induction or inhibition of anxious states, 
and numerous of interconnected limbic and 
cortical structures have been implicated in 
the emotional mechanisms which underlie 
and modulate anxious states (Millan, 
2003). These structures, including regions 
such as the hippocampus, lateral septum, 
and amygdala, express high levels of 
KCC2 and are also known to contain 
GABAergic pathways that may exert 
an inhibitory infl uence upon the release 
of many neurotransmitters known to 
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mediate anxiogenic actions (Kanaka et 
al., 2001;Okabe et al., 2003;Brambilla 
et al., 2003). For example, GABA exerts 
an inhibitory tone on corticolimbic 
noradrenergic ,  serotonergic ,  and 
dopaminercig projections, which are 
implicated in the pathophysiology 
of anxiety disorders (Tanaka et al., 
2000;Millan, 2003). In addition, a 
link between GABAergic system and 
neurosteroid modulation of anxiety 
states has been reported (Brambilla et al., 
2003;Maguire et al., 2005).
Many classical anxiolytic drugs, 
for example, benzodiazepines, operate 
by increasing the activity of GABAA 
receptors. The GABAA receptor subtypes 
responsible for anxiolysis are not clearly 
determined, but the prime candidates are 
the receptors that contain either α2 or α3 
subunits (Low et al., 2000;Dias et al., 
2005). In addition, mice heterozygous for 
deletion of the predominantly synaptic 
γ2 subunit show enhanced anxiety in 
several tests of innate and learned fear 
(Crestani et al., 1999). These mice show 
decreased synaptic clustering of GABAA 
receptors in the hippocampus and cerebral 
cortex, consistent with studies in patients 
suffering from panic attacks (Schlegel et 
al., 1994;Kaschka et al., 1995;Malizia et 
al., 1998). In addition, mice with targeted 
inactivation of GAD65 and GAT-1 display 
enhanced anxiety-related behavior (Kash 
et al., 1999;Chiu et al., 2005).
Tonic GABA inhibition has been 
suggested to play a role in the modulation 
of anxious states in female mice (Maguire 
et al., 2005). During the mouse estrous 
cycle, hormonal changes may alter the 
expression of δ subunit-containing GABAA 
receptors and thus the magnitude of the 
tonic GABA conductance (Maguire et al., 
2005). In late diestrus (high-progesterone 
phase), the expression of δ subunit-
containing GABAA receptors is increased. 
This leads to increased tonic inhibition 
and consequent reduction of neuronal 
excitability, which correspondingly 
results in decreased anxiety (Maguire et 
al., 2005). During the estrus phase (when 
serum progesterone levels are relatively 
low), tonic inhibition is reduced by 50%, 
which correspondingly increases anxiety 
(Maguire et al., 2005).
The KCC2 hy/nul l mice showed 
enhanced anxiety-like behavior in several 
behavioral tests. In the elevated plus-
maze, the mutant mice showed an anxiety-
like phenotype by avoiding the open arm 
entries almost completely, displaying less 
exploratory activity and head dippings, 
and by defecating more often than their 
wild-type littermates. Surprisingly, 
elevated plus-maze revealed that the wild-
type littermates displayed highly anxious 
behavior as well, but these mice were 
still signifi cantly less anxious compared 
to the KCC2-defi cient mice. In addition, 
as the results presented in III are from 
two separate cohorts of mice containing 
wild-type and KCC2hy/null littermate mice, 
and no difference between the cohorts 
were observed (i.e. the KCC2hy/null mice 
displayed more anxious behavior in both 
cohorts), we conclude that the KCC2hy/null 
mice displayed an enhanced anxiety-like 
behavior in the elevated plus-maze.
The mice were subsequently tested 
in the open field. In this test, the mice 
continued to show some signs of increased 
anxiety (abnormal rearing activity and 
increased defecation), but were similar 
to wild-type controls with respect to 
the time spent in the central part of the 
area, and the latency to enter the central 
part. In the light-dark exploration test 
(another unconditioned test of anxiety), 
the KCC2hy/null mice continued to show 
decreased rearing activity and increased 
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defecation, consistent with the results 
from the elevated plus-maze. In this 
model, however, no differences between 
the genotypes were detected regarding the 
conventional measures of anxiety: latency 
to leave the lit compartment and number 
of transitions between the light and 
dark compartments. This may be due to 
previous testing of the mice in the elevated 
plus-maze and open fi eld, as exploratory 
activity and emotionality have been shown 
to be sensitive to previous handling and 
testing (Voikar et al., 2004). However, 
the KCC2hy/null mice did continue to show 
abnormal rearing activity and increased 
defecation in the Y-maze test, consistent 
with the increased anxiety-like behavioral 
phenotype. Although the increased 
defecation in KCC2-defi cient mice might 
be interpreted as abnormalities in the 
gastrointestinal system (i.e. fast bowel, 
poor digestion), deficits in this system 
would be reflected in the mouse body 
weight, or in food/water intake. Indeed, 
the KCC2-deficient display reduced 
body weight compared to their wild-
type littermates, but this difference arises 
during the fi rst two postnatal weeks, after 
which the difference remains the same. In 
addition, we have measured the food and 
water intake in KCC2hy/null mice by using 
a comprehensive lab animal monitoring 
system (CLAMS) (Columbus Instruments, 
Columbus, OH), and found no difference 
in water or food intake between the 
genotypes (unpublished data not shown). 
Thus we conclude the increased defecation 
as a consequence of increased anxiety in 
the mice.
Benzodiazepines mediate their 
anxiolytic effects predominantly through 
synaptic GABAA receptors, and it has 
been hypothesized, for instance, that 
panic disorder might be due to abnormal 
activity of endogenous ligands of the 
benzodiazepine receptor (Nutt et al., 
1990). Thus the anxiety-related phenotype 
in KCC2 mutant mice might be induced 
due to compromized effects of endogenous 
benzodiazepine ligands on synaptic 
GABAergic receptors. Although estrous 
cycle may have a signifi cant role in the 
modulation of anxious states, we did not 
specifically address this question in the 
KCC2hy/null mice. We did not, however, 
observe any gender-specifi c differences in 
the anxiety-related phenotype in the KCC2 
mutant mice.
4.3.8 Morris water maze learning is 
impaired in cation-Cl- cotransporter 
isoform 2 mutant mice (III)
Several brain regions have been implicated 
in Morris water maze learning, including 
hippocampus, striatum, basal forebrain, 
and cerebellum (D’Hooge and De Deyn, 
2001). KCC2 is abundant in all of these 
regions and shows a particularly high 
expression in the hippocampal formation 
(Kanaka et al., 2001). Spatial learning in 
the water maze appears to depend upon 
the coordinated action of these different 
brain regions and the neurotransmitter 
systems that constitute a functionally 
integrated neural network. Mice with 
targeted deletion of GABAA receptor 
subunit α5, which is mainly localized to 
hippocampus (Sur et al., 1998;Sur et al., 
1999b), display enhanced water maze 
performance (Collinson et al., 2002). In 
addition, activation of the GABA system 
by benzodiazepines have been shown to 
interfere directly with the spatial learning 
abilities (McNaughton and Morris, 
1987;McNamara and Skeleton, 1993).
 In order to test whether KCC2-
deficiency has an effect on the mouse 
spatial learning capabilities, we tested the 
performance of KCC2hy/null mice in a water 
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maze. The mutant mice demonstrated a 
longer cumulative distance to the target 
than controls during the learning period, 
but were similarly able to shorten the 
distance to the platform. In the fi rst transfer 
test (also referred to as the probe trial), the 
KCC2hy/null mice displayed a decreased 
ability to locate the platform. During 
the second transfer test (performed after 
reversal learning) the mutant mice showed 
no preference for the new or old target 
location. The KCC2hy/null mice did not, 
however, differ from controls regarding 
performance in the visible platform test, 
thigmotaxis or distance swum during the 
test, which indicated normal motivation, 
as well as visual and swimming abilities. 
Also the swimming speed was not different 
compared to the wild-type controls. Our 
results thus suggest a possible role for 
KCC2 in spatial hippocampus-dependent 
learning.
4.3.9 Threshold for nociception is 
increased in cation-Cl- cotransporter 
isoform 2-defi cient mice (III)
Neuropathic pain that occurs after 
peripheral nerve injury depends on the 
hyperexcitability of lamina I neurons in the 
dorsal horn of the spinal cord (Woolf and 
Salter, 2000;Ji and Strichartz, 2004;Lewin 
et al., 2004). The underlying mechanism 
appears to involve a down-regulation in 
KCC2 expression and the consequent 
increase in [Cl-]i that causes GABA and 
glycine released from interneurons to 
depolarize the lamina I neurons instead 
of hyperpolarizing them (Coull et al., 
2003). The effect of benzodiazepines was 
not tested in this experimental setup. The 
KCC2 down-regulation is presumably 
mediated via BDNF (Rivera et al., 2002), 
as peripheral nerve injury activates 
microglia to release BDNF, which then 
acts on neuronal TrkB receptors causing 
the depolarizing shift in the neuronal anion 
gradient (Coull et al., 2005).
To investigate whether the KCC2hy/
null mice exhibited abnormalities in their 
somatosensory processing, we tested the 
sensitivity of KCC2hy/null mice to tactile 
and thermal stimuli. Thermal sensitivity 
was tested by warm water tail withdrawal 
and hot plate tests. In both tests, the 
traditionally used temperatures (52°C for 
hot plate and 49°C for tail withdrawal) 
revealed no difference between the 
genotypes. With lower temperatures 
(49°C for hot plate and 45°C for tail 
withdrawal), however, the KCC2hy/null 
displayed decreased responsiveness. The 
sensitivity for mechanical stimulus was 
also decreased in the KCC2hy/null mice as 
assessed by von Frey hairs.
Our results were in obvious contrast 
with the report of Coull and colleagues 
(2003) showing that intrathecal KCC2 
ant isense  knock-down increased 
mechanical and thermal sensitivity in 
the same tests. The discrepancy may 
be explained by the universal reduction 
of KCC2 in KCC2hy/null mice versus the 
local spinal KCC2 reduction observed by 
Coull and coworkers (2003). Electrical 
stimulation in widespread sites in the 
brain, including the sensory cortex, 
thalamus, hypothalamus, midbrain, 
pons, and medulla have been shown 
to produce inhibitory effects on spinal 
nociceptive processing (Gebhart, 2004). 
This descending modulation of spinal 
nociceptive processing can also be 
facilitatory as well as biphasic, is often 
tonically active, and the strength of this 
supraspinal modulation compared to direct 
spinal action depends on the activated 
brain region and on the intensity of the 
stimulus (Gebhart, 2004). Especially 
the rostral ventromedial medulla and the 
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periaqueductal gray have been identifi ed 
as important sites to descend inhibition 
of spinal nociceptive processing (Hunt 
and Mantyh, 2001;Gebhart, 2004). Local 
microinjections of GABAA receptor 
antagonists to these two sites have been 
shown to result in antinociception in 
the spinal dorsal horn (Moreau and 
Fields, 1986;Drower and Hammond, 
1988;Heinricher and Kaplan, 1991), 
and the behavioral responses in tests of 
nociception, including tail withdrawal, are 
subject to modulation by these supraspinal 
sites. Thus a plausible mechanism for the 
reduced sensitivity in KCC2hy/null mice 
would be reduced GABAergic inhibition 
in the central pain modulatory neurons.
4.3.10 Cation-Cl- cotransporter 
isoform 2 mutant mice show increased 
susceptibility to seizures (III)
Epilepsies are characterized by recurrent 
seizures, which can cause motor, 
sensory, cognitive, psychic or autonomic 
disturbances (Steinlein, 2004). The GABA 
neurotransmission system has been 
shown to be involved in epilepsy, and 
the modifi cations within the GABAergic 
system leading to epileptic states can 
occur at all levels of integration, from 
GABAA receptors (DeLorey et al., 1998) to 
interneuron networks (Cossart et al., 2005). 
Experiments in genetically modifi ed mice 
imply that GABAA receptor subunits β3, 
α1, and δ are associated with alterations 
in seizure susceptibility (Homanics et 
al., 1997;DeLorey et al., 1998;Mihalek 
et al., 2001;Kralic et al., 2002a) (table 6). 
Targeted deletions of β3 and α1 subunits 
result in spontaneous seizures or reduced 
seizure threshold (Homanics et al., 
1997;DeLorey et al., 1998;Kralic et al., 
2002a). GABAA receptor δ subunit KO 
mice show increased seizure susceptibility 
(Mihalek et al., 2001), and periodic 
alterations in the δ subunit levels during 
mouse estrous cycle have been implicated 
to affect the mouse seizure susceptibility 
level (Maguire et al., 2005). Finally, 
mutations in the GABAA receptor α1, γ2, 
and δ subunits have been identified in 
patients with different inherited epileptic 
disorders (Wallace et al., 2001;Baulac et 
al., 2001;Harkin et al., 2002;Kananura et 
al., 2002;Dibbens et al., 2004;Maljevic et 
al., 2006).
In human subiculum tissues from 
patients with temporal lobe epilepsy, 
GABAergic synapses have been shown 
to be still operative, but to display unique 
excitatory effects due to a significant 
positive shift of the reversal potential of 
GABA-mediated currents (Cohen et al., 
2002). This is probably due to alterations 
in the expression levels of subicular 
NKCC1 and KCC2, as in epileptic tissues 
from temporal lobe epilepsy patients, 
NKCC1 was upregulated and KCC2 was 
down-regulated (Cohen et al., 2002;Palma 
et al., 2006). In addition, application of 
GABAA receptor antagonists in slice 
preparations suppressed the ongoing 
activity, instead of generating epileptic 
activity as observed in control conditions 
(Cohen et al., 2002). The results implied 
that depolarizing GABA currents in the 
subiculum contribute to the mechanism of 
cortical epileptic discharges.
In order to investigate whether 
KCC2 defi ciency results in altered seizure 
susceptibility, we tested the KCC2hy/null 
mice in a GABAA receptor antagonist PTZ-
induced seizure model, which is thought 
to mimic generalized seizures in humans 
(Andre et al., 1998). The KCC2hy/null mice 
were more susceptible to PTZ-induced 
seizures than wild-type controls, consistent 
with the fi ndings in mice heterozygous for 
a KCC2 mutation (Woo et al., 2002). This 
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result was not, however, consistent with the 
results from the epileptic subicular tissues, 
in which GABAA receptor antagonists 
suppressed the interictal activity. This 
implies that, at least in some neurons of 
the KCC2-defi cient mice, synaptic GABA 
responses are still inhibitory and PTZ 
induces seizures by blocking both the 
synaptic and tonic GABAergic inhibition. 
An alternative explanation is that the 
KCC2-defi cient mice display depolarizing 
synaptic GABA responses that are blocked 
by PTZ, and thus PTZ might have a partial 
anticonvulsant effect in KCC2-defi cient 
mice. This effect would, however, 
be overrun by the PTZ blockade of 
extrasynaptic GABAA receptors and by the 
consequent abolishment of all inhibitory 
GABAergic neurotransmission in the 
brain. In addition, possible compensations 
in the GABAergic system may have an 
affect on the seizure susceptibility level 
observed in KCC2hy/null mice.
We conclude that the decreased 
seizure susceptibility in KCC2-defi cient 
mice implies a critical role for KCC2 in 
the control of neuronal excitability, and 
polymorphisms in KCC2 are obvious 
candidates associated with human 
epilepsies.
4.3.11 Female cation-Cl- cotransporter 
isoform 2-defi cient mice show disruption 
in prepulse inhibition (unpublished 
results)
Disturbances in cortical and hippocampal 
GABAergic interneuron networks have 
been linked to a broad array of disorders 
in cognitive function, like those seen 
in schizophrenia (Benes and Berretta, 
2001;Lewis et al., 2005). GABAergic 
interneurons are remarkably diverse and 
complex in nature and engage in complex 
interactions not only with the excitatory 
neurons, but also with one another (Woo 
and Lu, 2006). Thus defects in even one 
component of these interneuron networks 
may potentially have profound effects 
of local circuits as well as larger scale 
macrocircuits. Within the corticolimbic 
system, GABAergic networks regulate 
the generation of oscillatory rhythms, 
discriminative information processing, and 
gating of sensory information. All of these 
functions may be abnormal in patients 
with cognitive function disorders (Benes 
and Berretta, 2001).
In humans, disruption of PPI of startle 
response is manifested in neuropsychiatric 
disorders characterized by sensorimotor 
gating defi cit. Studies in rats have shown 
that PPI is mostly regulated by complex 
neuronal interactions between limbic 
cortex (including e.g. temporal cortex, 
medial prefrontal cortex, hippocampus, 
and amygdala), the ventral striatum, 
the ventral pallidum, and pontine 
tegmentum (Swerdlow et al., 2001). The 
neurotransmitter systems implicated in 
the proper functioning of this circuitry 
are known to include dopaminergic and 
other monoaminergic systems, as well as 
GABAergic and glutamatergic systems 
(Carlsson et al., 2001). GABAergic 
inhibitory control of the dopaminergic and 
other monoaminergic systems appears to 
be important for the normal expression 
of PPI (Swerdlow et al., 2001). Direct 
evidence for the role of GABAergic 
neurotransmission in the expression of 
PPI has been obtained from genetically 
modified mice (table 6). Inactivation 
of several components of the GABA 
neurotransmitter system, including GAT-
1, GAD65, and GABAA receptor subunits 
α3 and α5, result in mice with deficits 
in PPI (Heldt et al., 2004;Hauser et al., 
2005;Chiu et al., 2005;Yee et al., 2005). In 
addition, studies in rats have shown that 
Results and Discussion
50
microinjections of the GABAA receptor 
antagonist picrotoxin into amygdala, 
prefrontal cortex, and hippocampus disrupt 
PPI (Japha and Koch, 1999;Fendt et al., 
2000), whereas intraperitoneal treatment 
of mice with diazepam improves PPI 
(Ouagazzal et al., 2001).
To assess the sensorimotor 
gating of KCC2hy/null mice, we used the 
paradigm of PPI of the acoustic startle 
response. The mice showed no difference 
between the genotypes and the gender in 
the startle response to the pulse stimulus 
alone (data not shown, F1.109 = 0.57, p > 
0.05). In the PPI analysis, the magnitude 
of PPI (percent inhibition) increased 
with increasing intensity of the prepulse 
stimulus for both wild-type and KCC2hy/
null mice (Fig. 3A, B. effect of prepulse 
intensities, F3.327 = 307, p < 0.001). The 
wild-type female mice displayed enhanced 
PPI compared to the wild-type male mice, 
but this gender difference between the 
PPI levels was not apparent in KCC2-
defi cient mice. A marked attenuation of 
PPI compared wild-type littermates was 
seen in the female KCC2-defi cient mice, 
but not in male mice. These fi ndings were 
supported by a 2-way repeated measures 
ANOVA which yielded signifi cant effects 
of prepulse intensities (F3.327 = 307, p < 
0.001), and of sex (F1.109 = 11.2, p < 0.01), 
and a signifi cant interaction between sex 
and genotype (F1.109 = 4.44, p < 0.05). 
Post hoc analysis detected a significant 
interaction between sex and genotype in 
female (p < 0.01), but not in male mice (p 
> 0.05). This implies that females in our 
(C57/BL6 x 129S2)F1 hybrid background 
show enhanced levels of PPI compared to 
males, and that this enhancement of PPI is 
abolished by KCC2 defi ciency.
Previous studies have identified 
sex differences in acoustic startle and PPI 
Fig. 4. PPI in KCC2hy/null male and female mice. PPI was indexed by percent inhibition, 
defi ned as the percent reduction in reactivity in prepulse-plus-pulse trials relative to 
pulse alone trials. A) Increasing prepulse intensity led to similarly increased magnitude 
of PPI in both KCC2hy/null male and wild-type male mice. B) The normal enhancement of 
PPI was abolished in KCC2hy/null female mice, a marked attenuation of PPI was seen at 
every prepulse intensity tested. Data represent mean ± SEM. ##p < 0.05 between the 
genotypes by two way ANOVA followed by Newman-Keuls post-hoc test.
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in humans and rodents (Swerdlow et al., 
1993;Lehmann et al., 1999). Specifi cally, 
PPI fluctuates across the estrous or 
menstrual cycle, implicating a role for 
estrogen and progesterone in the regulation 
of sensorimotor gating (Swerdlow et 
al., 1993;Swerdlow et al., 1997;Koch, 
1998). In addition, studies using inbred 
mouse strains have shown a significant 
contribution of genetic infl uences to the 
sex-dependent differences in PPI responses 
(Willott et al., 2003). The sex-specific 
nature of the PPI attenuation observed 
in KCC2 defi ciency suggests that KCC2 
activity or expression might be regulated 
by sex hormones or that KCC2 expression 
displays sex-specifi c differences in certain 
limbic areas that regulate the normal 
expression of PPI, such as hippocampus, 
basolateral amygdala, striatum, and 
substantia nigra reticulata (Swerdlow et 
al., 2001). Indeed, sex-specifi c differences 
in KCC2 expression has been described 
in rat substantia nigra (Galanopoulou et 
al., 2003). In addition, sex hormones have 
been shown to regulate the expression of 
KCC2 mRNA in juvenile rat substantia 
nigra (Galanopoulou and Moshe, 2003). 
In this brain region, testosterone and 
dihydrosterone were shown to up-regulate 
KCC2 mRNA in both sexes, whereas 
estradiol down-regulated the transcript 
expression in males but not in females 
(Galanopoulou et al., 2003). Unfortunately, 
the possible infl uence of the estrous cycle 
upon KCC2 mRNA expression has not 
been described.
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5. CONCLUDING REMARKS
• KCC isoforms and NKCC1 undergo dramatic spatiotemporal changes in their 
expression during rodent embryonic CNS development. KCC2 mRNA expres-
sion displays developmental up-regulation and follows the rostro-caudal pro-
gression pattern of neuronal maturation. NKCC1 and KCC4 transcripts are 
highly expressed in the proliferative zones of subcortical regions at the peak of 
neurogenesis. These expression profi les suggest a role for CCC isoforms in the 
maturation of synaptic responses as well as in the regulation of neuronal prolif-
eration during embryogenesis.
• KCC2 is a critical player in creating and maintaining low neuronal [Cl-]i, which 
is required for hyperpolarizing GABA and glycine neurotransmitter-mediated 
responses. Complete disruption of the KCC2-encoding Slc12a5 gene in mice 
leads to death immediately after birth, whereas KCC2 knock-down animals that 
retain 15-20% of the normal KCC2 levels are viable and display several behav-
ioral phenotypes. These mice exhibit anxiety-like behavior and seizure suscepti-
bility as well as impaired water-maze performance and alterations in nociceptive 
processing. This thesis provides the fi rst report concerning the role of KCC2 in 
adult mouse behavior and suggests that KCC2 may have implications for human 
neurological and psychiatric disorders, such as epilepsy, anxiety, and pain.
• The role of KCC2 in GABAergic neurotransmission is emphasized in the fast 
phasic inhibition mediated by postsynaptic GABAA receptors. KCC2 defi ciency 
leads to compromised hyperpolarizing GABA responses which are directly cor-
related with mice behavior, whereas reduced tonic GABA currents are not nec-
essarily manifested in the animal behavior.
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